Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxj3
|
ENSMUSG00000032998.10 | forkhead box J3 |
Tbl1xr1
|
ENSMUSG00000027630.8 | transducin (beta)-like 1X-linked receptor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr4_119589534_119589697 | Foxj3 | 31727 | 0.095261 | -0.40 | 4.3e-01 | Click! |
chr4_119614832_119614983 | Foxj3 | 6435 | 0.150490 | 0.38 | 4.6e-01 | Click! |
chr4_119540199_119540879 | Foxj3 | 17 | 0.931389 | -0.33 | 5.3e-01 | Click! |
chr4_119539797_119539948 | Foxj3 | 93 | 0.774069 | -0.28 | 5.9e-01 | Click! |
chr3_22078075_22078419 | Tbl1xr1 | 963 | 0.466167 | -0.98 | 8.5e-04 | Click! |
chr3_22115281_22115449 | Tbl1xr1 | 876 | 0.623218 | -0.94 | 5.3e-03 | Click! |
chr3_22190624_22190775 | Tbl1xr1 | 12493 | 0.228153 | 0.93 | 7.7e-03 | Click! |
chr3_22188790_22188958 | Tbl1xr1 | 14318 | 0.224314 | -0.88 | 2.1e-02 | Click! |
chr3_22102432_22102611 | Tbl1xr1 | 11968 | 0.180724 | -0.86 | 2.7e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chrY_90740044_90740606 | 9.02 |
Mid1-ps1 |
midline 1, pseudogene 1 |
12732 |
0.18 |
chr4_108780980_108781662 | 8.88 |
Zfyve9 |
zinc finger, FYVE domain containing 9 |
523 |
0.73 |
chr6_149225033_149225369 | 8.11 |
1700003I16Rik |
RIKEN cDNA 1700003I16 gene |
10016 |
0.16 |
chr9_74894770_74895613 | 7.52 |
Onecut1 |
one cut domain, family member 1 |
28707 |
0.13 |
chr12_104343910_104344587 | 6.96 |
Serpina3k |
serine (or cysteine) peptidase inhibitor, clade A, member 3K |
5762 |
0.12 |
chr17_65594339_65595183 | 6.87 |
Vapa |
vesicle-associated membrane protein, associated protein A |
209 |
0.93 |
chr7_25076421_25076788 | 6.59 |
Zfp574 |
zinc finger protein 574 |
601 |
0.6 |
chr6_144070883_144071211 | 6.51 |
Sox5os1 |
SRY (sex determining region Y)-box 5, opposite strand 1 |
49139 |
0.17 |
chrX_23710209_23710816 | 6.46 |
Wdr44 |
WD repeat domain 44 |
17353 |
0.28 |
chr1_50806470_50806812 | 6.33 |
Gm28321 |
predicted gene 28321 |
8734 |
0.28 |
chr2_34775525_34776380 | 6.22 |
Hspa5 |
heat shock protein 5 |
1105 |
0.4 |
chr12_104342354_104343298 | 6.20 |
Serpina3k |
serine (or cysteine) peptidase inhibitor, clade A, member 3K |
4340 |
0.13 |
chr2_48403972_48404299 | 6.15 |
Gm13472 |
predicted gene 13472 |
16098 |
0.2 |
chr11_28696545_28697113 | 6.04 |
2810471M01Rik |
RIKEN cDNA 2810471M01 gene |
15265 |
0.17 |
chr3_94398519_94398670 | 6.03 |
Lingo4 |
leucine rich repeat and Ig domain containing 4 |
77 |
0.91 |
chr3_58520131_58520481 | 6.01 |
Eif2a |
eukaryotic translation initiation factor 2A |
5515 |
0.16 |
chr4_143211420_143211595 | 5.95 |
Prdm2 |
PR domain containing 2, with ZNF domain |
1198 |
0.39 |
chr19_12700970_12701121 | 5.80 |
Keg1 |
kidney expressed gene 1 |
5231 |
0.11 |
chr9_106234042_106234256 | 5.78 |
Alas1 |
aminolevulinic acid synthase 1 |
2935 |
0.14 |
chr19_12670669_12671099 | 5.75 |
Olfr1442 |
olfactory receptor 1442 |
310 |
0.79 |
chr9_122848915_122849207 | 5.73 |
Gm47140 |
predicted gene, 47140 |
643 |
0.55 |
chr9_55541381_55541949 | 5.55 |
Isl2 |
insulin related protein 2 (islet 2) |
458 |
0.61 |
chr2_72204001_72204398 | 5.53 |
Rapgef4 |
Rap guanine nucleotide exchange factor (GEF) 4 |
5400 |
0.2 |
chr8_36246396_36246684 | 5.48 |
Lonrf1 |
LON peptidase N-terminal domain and ring finger 1 |
2976 |
0.27 |
chr1_162986828_162987029 | 5.45 |
Fmo3 |
flavin containing monooxygenase 3 |
2400 |
0.25 |
chr17_81385422_81385814 | 5.41 |
Gm50044 |
predicted gene, 50044 |
14785 |
0.24 |
chr1_21257119_21257270 | 5.40 |
Gsta3 |
glutathione S-transferase, alpha 3 |
3673 |
0.13 |
chr7_97414019_97414355 | 5.33 |
Thrsp |
thyroid hormone responsive |
3332 |
0.16 |
chr10_87865511_87865999 | 5.32 |
Igf1os |
insulin-like growth factor 1, opposite strand |
2374 |
0.3 |
chr9_74892080_74892501 | 5.17 |
Onecut1 |
one cut domain, family member 1 |
25806 |
0.14 |
chr1_162964214_162964365 | 5.09 |
Gm37273 |
predicted gene, 37273 |
18725 |
0.14 |
chr11_16812999_16813190 | 5.07 |
Egfros |
epidermal growth factor receptor, opposite strand |
17608 |
0.2 |
chr9_122864088_122864252 | 4.97 |
Zfp445 |
zinc finger protein 445 |
1764 |
0.21 |
chr10_91321221_91321411 | 4.97 |
Gm47082 |
predicted gene, 47082 |
10971 |
0.22 |
chr4_143188898_143189626 | 4.95 |
Prdm2 |
PR domain containing 2, with ZNF domain |
5473 |
0.15 |
chr4_72946096_72946247 | 4.94 |
Gm25653 |
predicted gene, 25653 |
39833 |
0.16 |
chr1_21324523_21325070 | 4.92 |
Gm21909 |
predicted gene, 21909 |
8476 |
0.1 |
chr3_149181265_149181842 | 4.89 |
Gm42647 |
predicted gene 42647 |
28718 |
0.19 |
chr10_4605740_4606032 | 4.86 |
Esr1 |
estrogen receptor 1 (alpha) |
5707 |
0.24 |
chr12_57515437_57515691 | 4.74 |
Gm2568 |
predicted gene 2568 |
5060 |
0.18 |
chr8_107137910_107138315 | 4.73 |
Cyb5b |
cytochrome b5 type B |
12528 |
0.13 |
chr7_89717748_89718025 | 4.70 |
Me3 |
malic enzyme 3, NADP(+)-dependent, mitochondrial |
18845 |
0.18 |
chr9_110985950_110986443 | 4.69 |
1700061E17Rik |
RIKEN cDNA 1700061E17 gene |
5 |
0.94 |
chr3_51227758_51227949 | 4.66 |
Noct |
nocturnin |
3383 |
0.18 |
chr1_67160568_67161028 | 4.64 |
Cps1 |
carbamoyl-phosphate synthetase 1 |
37772 |
0.17 |
chr17_81378554_81378979 | 4.62 |
Gm50044 |
predicted gene, 50044 |
7933 |
0.26 |
chr5_8981190_8981526 | 4.62 |
Crot |
carnitine O-octanoyltransferase |
786 |
0.52 |
chr9_55281590_55281872 | 4.61 |
Nrg4 |
neuregulin 4 |
1841 |
0.33 |
chr10_93075982_93076133 | 4.59 |
Cfap54 |
cilia and flagella associated protein 54 |
5539 |
0.22 |
chr11_7816093_7816451 | 4.53 |
Gm27393 |
predicted gene, 27393 |
70233 |
0.13 |
chr13_4203084_4203283 | 4.46 |
Akr1c13 |
aldo-keto reductase family 1, member C13 |
9325 |
0.13 |
chr2_28882435_28882761 | 4.45 |
Ddx31 |
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 31 |
25457 |
0.13 |
chr16_42998828_42999221 | 4.42 |
Ndufs5-ps |
NADH:ubiquinone oxidoreductase core subunit S5, pseudogene |
43393 |
0.16 |
chr8_93165469_93165620 | 4.42 |
Ces1d |
carboxylesterase 1D |
4431 |
0.16 |
chr14_30542112_30542288 | 4.40 |
Tkt |
transketolase |
6159 |
0.16 |
chr1_51740463_51740849 | 4.37 |
Gm28055 |
predicted gene 28055 |
6287 |
0.22 |
chr18_29774940_29775095 | 4.37 |
Gm7917 |
predicted gene 7917 |
117421 |
0.07 |
chr5_137115772_137116317 | 4.36 |
Trim56 |
tripartite motif-containing 56 |
163 |
0.92 |
chr6_143857220_143857571 | 4.35 |
Sox5 |
SRY (sex determining region Y)-box 5 |
89693 |
0.09 |
chr10_81135059_81135271 | 4.34 |
Zbtb7a |
zinc finger and BTB domain containing 7a |
55 |
0.93 |
chr12_103991999_103992602 | 4.34 |
Serpina11 |
serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 11 |
2343 |
0.16 |
chr1_21259850_21260251 | 4.33 |
Gsta3 |
glutathione S-transferase, alpha 3 |
6529 |
0.11 |
chr6_141348213_141348590 | 4.32 |
Gm10400 |
predicted gene 10400 |
7848 |
0.26 |
chr16_42947764_42948084 | 4.30 |
Ndufs5-ps |
NADH:ubiquinone oxidoreductase core subunit S5, pseudogene |
7707 |
0.21 |
chr11_110101538_110102129 | 4.30 |
Abca8a |
ATP-binding cassette, sub-family A (ABC1), member 8a |
5855 |
0.27 |
chr8_82402195_82403147 | 4.29 |
Il15 |
interleukin 15 |
101 |
0.98 |
chr13_31506338_31507020 | 4.28 |
Foxq1 |
forkhead box Q1 |
49455 |
0.1 |
chr9_55280024_55280330 | 4.28 |
Nrg4 |
neuregulin 4 |
3395 |
0.23 |
chr10_87896571_87896873 | 4.26 |
Igf1os |
insulin-like growth factor 1, opposite strand |
33341 |
0.15 |
chr4_122945294_122945445 | 4.25 |
Mfsd2a |
major facilitator superfamily domain containing 2A |
14621 |
0.13 |
chr8_93186065_93186216 | 4.23 |
Gm45909 |
predicted gene 45909 |
5218 |
0.15 |
chr4_47366562_47366857 | 4.23 |
Tgfbr1 |
transforming growth factor, beta receptor I |
13099 |
0.22 |
chr1_127899545_127899941 | 4.23 |
Rab3gap1 |
RAB3 GTPase activating protein subunit 1 |
1170 |
0.47 |
chr5_147744758_147744909 | 4.22 |
Gm43156 |
predicted gene 43156 |
683 |
0.71 |
chr2_181529212_181529615 | 4.20 |
Dnajc5 |
DnaJ heat shock protein family (Hsp40) member C5 |
8466 |
0.1 |
chr9_7873275_7873556 | 4.19 |
Birc3 |
baculoviral IAP repeat-containing 3 |
229 |
0.93 |
chr7_63899068_63899509 | 4.18 |
Gm27252 |
predicted gene 27252 |
1314 |
0.37 |
chr3_34020715_34021194 | 4.16 |
Fxr1 |
fragile X mental retardation gene 1, autosomal homolog |
846 |
0.39 |
chr6_59348049_59348218 | 4.15 |
Gprin3 |
GPRIN family member 3 |
78161 |
0.11 |
chr10_87905188_87905714 | 4.14 |
Igf1os |
insulin-like growth factor 1, opposite strand |
42070 |
0.13 |
chr6_149149841_149149992 | 4.13 |
Etfbkmt |
electron transfer flavoprotein beta subunit lysine methyltransferase |
8270 |
0.13 |
chr15_39816605_39817118 | 4.11 |
Gm16291 |
predicted gene 16291 |
19816 |
0.18 |
chr19_40180011_40180165 | 4.11 |
Cyp2c70 |
cytochrome P450, family 2, subfamily c, polypeptide 70 |
7198 |
0.16 |
chr1_59386656_59386968 | 4.09 |
Gm29016 |
predicted gene 29016 |
7882 |
0.2 |
chr1_162987339_162987541 | 4.07 |
Fmo3 |
flavin containing monooxygenase 3 |
2912 |
0.22 |
chr7_98352590_98353259 | 4.05 |
Tsku |
tsukushi, small leucine rich proteoglycan |
7155 |
0.18 |
chr19_18145861_18146289 | 4.04 |
Gm18610 |
predicted gene, 18610 |
59720 |
0.14 |
chr15_41948299_41948658 | 4.04 |
Gm24751 |
predicted gene, 24751 |
519 |
0.8 |
chr11_80974932_80975087 | 4.04 |
Gm11416 |
predicted gene 11416 |
71785 |
0.1 |
chr7_63923519_63923771 | 4.04 |
Klf13 |
Kruppel-like factor 13 |
1225 |
0.37 |
chr2_146429524_146429960 | 4.01 |
Ralgapa2 |
Ral GTPase activating protein, alpha subunit 2 (catalytic) |
16866 |
0.26 |
chr3_21371390_21371542 | 4.01 |
Gm29137 |
predicted gene 29137 |
102376 |
0.08 |
chr8_93151191_93151478 | 3.98 |
Gm45910 |
predicted gene 45910 |
2782 |
0.2 |
chr12_45069728_45070323 | 3.97 |
Stxbp6 |
syntaxin binding protein 6 (amisyn) |
4087 |
0.24 |
chr19_44394517_44394772 | 3.97 |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
12046 |
0.14 |
chr5_145139980_145140681 | 3.96 |
Bud31 |
BUD31 homolog |
32 |
0.55 |
chr7_84129291_84129727 | 3.95 |
Abhd17c |
abhydrolase domain containing 17C |
18306 |
0.14 |
chr1_50806813_50807031 | 3.95 |
Gm28321 |
predicted gene 28321 |
8453 |
0.28 |
chr11_28695418_28695578 | 3.94 |
2810471M01Rik |
RIKEN cDNA 2810471M01 gene |
13934 |
0.17 |
chr1_67207008_67207510 | 3.94 |
Gm15668 |
predicted gene 15668 |
41941 |
0.15 |
chr8_93179883_93180034 | 3.93 |
Ces1d |
carboxylesterase 1D |
4669 |
0.15 |
chr4_108075287_108075438 | 3.93 |
Scp2 |
sterol carrier protein 2, liver |
3943 |
0.17 |
chr2_160362942_160363707 | 3.93 |
Mafb |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein B (avian) |
3741 |
0.3 |
chr11_72683212_72683363 | 3.92 |
Ankfy1 |
ankyrin repeat and FYVE domain containing 1 |
6719 |
0.18 |
chr19_44396138_44396537 | 3.91 |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
10353 |
0.14 |
chr9_108307554_108308248 | 3.89 |
Rhoa |
ras homolog family member A |
1072 |
0.25 |
chr5_66094198_66094378 | 3.88 |
Rbm47 |
RNA binding motif protein 47 |
3903 |
0.15 |
chr10_69926234_69926547 | 3.88 |
Ank3 |
ankyrin 3, epithelial |
257 |
0.96 |
chr11_69098275_69098686 | 3.87 |
Per1 |
period circadian clock 1 |
468 |
0.58 |
chr15_3476580_3476767 | 3.86 |
Ghr |
growth hormone receptor |
5029 |
0.32 |
chr3_94705046_94705225 | 3.85 |
Selenbp2 |
selenium binding protein 2 |
11476 |
0.11 |
chr9_55279483_55279657 | 3.85 |
Nrg4 |
neuregulin 4 |
4002 |
0.21 |
chr2_148037591_148038164 | 3.84 |
9030622O22Rik |
RIKEN cDNA 9030622O22 gene |
393 |
0.84 |
chrY_90807232_90807393 | 3.83 |
Gm47283 |
predicted gene, 47283 |
16861 |
0.16 |
chr4_88893074_88893256 | 3.83 |
Ifne |
interferon epsilon |
12964 |
0.08 |
chr13_55252702_55252865 | 3.83 |
Gm47816 |
predicted gene, 47816 |
1618 |
0.3 |
chr3_5425056_5425268 | 3.81 |
4930555M17Rik |
RIKEN cDNA 4930555M17 gene |
90171 |
0.09 |
chr11_5096479_5096889 | 3.81 |
Rhbdd3 |
rhomboid domain containing 3 |
2242 |
0.19 |
chr4_102557092_102557428 | 3.80 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
12835 |
0.29 |
chr19_30516882_30517255 | 3.79 |
Gm50264 |
predicted gene, 50264 |
14861 |
0.16 |
chr1_166000310_166001131 | 3.79 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
1889 |
0.25 |
chrX_169972936_169973308 | 3.79 |
Mid1 |
midline 1 |
237 |
0.91 |
chr3_138287619_138288216 | 3.78 |
Adh1 |
alcohol dehydrogenase 1 (class I) |
10266 |
0.12 |
chr2_103461502_103462486 | 3.77 |
Elf5 |
E74-like factor 5 |
13256 |
0.17 |
chr8_105067070_105067251 | 3.77 |
Ces3a |
carboxylesterase 3A |
13507 |
0.09 |
chr13_4041060_4041239 | 3.76 |
Gm18857 |
predicted gene, 18857 |
5904 |
0.14 |
chr7_128613521_128613682 | 3.73 |
Inpp5f |
inositol polyphosphate-5-phosphatase F |
2241 |
0.21 |
chr11_84193018_84193169 | 3.73 |
Acaca |
acetyl-Coenzyme A carboxylase alpha |
2345 |
0.26 |
chr12_100421631_100422293 | 3.72 |
Gm48381 |
predicted gene, 48381 |
22698 |
0.15 |
chr10_42771201_42771501 | 3.71 |
Sec63 |
SEC63-like (S. cerevisiae) |
9545 |
0.16 |
chr1_51751367_51751637 | 3.71 |
Gm28055 |
predicted gene 28055 |
4559 |
0.23 |
chr19_32788703_32789372 | 3.70 |
Pten |
phosphatase and tensin homolog |
22188 |
0.22 |
chr3_97636100_97636462 | 3.70 |
Fmo5 |
flavin containing monooxygenase 5 |
7398 |
0.14 |
chr1_97770980_97771325 | 3.70 |
Ppip5k2 |
diphosphoinositol pentakisphosphate kinase 2 |
741 |
0.49 |
chr18_17623971_17624154 | 3.70 |
4930545E07Rik |
RIKEN cDNA 4930545E07 gene |
43072 |
0.18 |
chr5_130009032_130009183 | 3.69 |
Asl |
argininosuccinate lyase |
5615 |
0.12 |
chr13_16574847_16575001 | 3.69 |
Gm48497 |
predicted gene, 48497 |
41103 |
0.17 |
chr8_77057050_77057484 | 3.68 |
Nr3c2 |
nuclear receptor subfamily 3, group C, member 2 |
70746 |
0.11 |
chr3_97645418_97646002 | 3.68 |
Prkab2 |
protein kinase, AMP-activated, beta 2 non-catalytic subunit |
12483 |
0.13 |
chr1_21246529_21246960 | 3.68 |
Gsta3 |
glutathione S-transferase, alpha 3 |
6115 |
0.12 |
chr19_37078496_37078665 | 3.67 |
Gm22714 |
predicted gene, 22714 |
70582 |
0.09 |
chr14_61427627_61427794 | 3.66 |
Kpna3 |
karyopherin (importin) alpha 3 |
12164 |
0.14 |
chr4_53201741_53202070 | 3.66 |
4930412L05Rik |
RIKEN cDNA 4930412L05 gene |
15656 |
0.18 |
chr5_135685581_135685753 | 3.65 |
Por |
P450 (cytochrome) oxidoreductase |
3369 |
0.13 |
chr11_61355295_61355921 | 3.65 |
Slc47a1 |
solute carrier family 47, member 1 |
10044 |
0.13 |
chr11_104441052_104441411 | 3.65 |
Kansl1 |
KAT8 regulatory NSL complex subunit 1 |
471 |
0.79 |
chr6_6206187_6206411 | 3.64 |
Slc25a13 |
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 13 |
10819 |
0.23 |
chr6_24610042_24610446 | 3.64 |
Lmod2 |
leiomodin 2 (cardiac) |
12482 |
0.14 |
chr4_102576883_102577034 | 3.63 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
6863 |
0.31 |
chr6_24610714_24610926 | 3.63 |
Lmod2 |
leiomodin 2 (cardiac) |
13058 |
0.14 |
chr5_147312834_147312985 | 3.63 |
Cdx2 |
caudal type homeobox 2 |
5639 |
0.11 |
chr3_138280557_138280953 | 3.61 |
Adh1 |
alcohol dehydrogenase 1 (class I) |
3104 |
0.16 |
chr17_35814760_35815402 | 3.61 |
Ier3 |
immediate early response 3 |
6603 |
0.07 |
chr10_87051307_87051578 | 3.60 |
1700113H08Rik |
RIKEN cDNA 1700113H08 gene |
6603 |
0.2 |
chr13_4577869_4578048 | 3.60 |
Akr1c21 |
aldo-keto reductase family 1, member C21 |
801 |
0.61 |
chr10_75782918_75783155 | 3.60 |
Gstt3 |
glutathione S-transferase, theta 3 |
1622 |
0.19 |
chr5_134312402_134312749 | 3.60 |
Gtf2i |
general transcription factor II I |
553 |
0.67 |
chr6_51171594_51172183 | 3.58 |
Mir148a |
microRNA 148a |
98022 |
0.07 |
chr19_26823384_26823535 | 3.57 |
4931403E22Rik |
RIKEN cDNA 4931403E22 gene |
448 |
0.84 |
chr1_160280517_160280905 | 3.57 |
Rabgap1l |
RAB GTPase activating protein 1-like |
6627 |
0.14 |
chr8_40882534_40882732 | 3.57 |
Slc7a2 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 |
7685 |
0.16 |
chr12_45065771_45065940 | 3.56 |
Stxbp6 |
syntaxin binding protein 6 (amisyn) |
8257 |
0.21 |
chr9_74894074_74894225 | 3.53 |
Onecut1 |
one cut domain, family member 1 |
27665 |
0.13 |
chr9_55253735_55254087 | 3.53 |
Nrg4 |
neuregulin 4 |
11450 |
0.18 |
chr13_101679671_101680043 | 3.52 |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
12486 |
0.22 |
chr7_16598127_16598332 | 3.51 |
Gm29443 |
predicted gene 29443 |
15595 |
0.09 |
chr6_27968118_27968298 | 3.51 |
Mir592 |
microRNA 592 |
31458 |
0.23 |
chrX_140591571_140591781 | 3.50 |
AL683809.1 |
TSC22 domain family, member 3 (Tsc22d3), pseuodgene |
8077 |
0.17 |
chr19_44398583_44398737 | 3.50 |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
8030 |
0.15 |
chr3_130694798_130695032 | 3.49 |
Ostc |
oligosaccharyltransferase complex subunit (non-catalytic) |
1707 |
0.27 |
chr15_99033646_99034208 | 3.49 |
Tuba1c |
tubulin, alpha 1C |
3606 |
0.11 |
chr4_76963069_76963220 | 3.49 |
Gm23159 |
predicted gene, 23159 |
4646 |
0.28 |
chr13_103916686_103916837 | 3.49 |
Erbin |
Erbb2 interacting protein |
3534 |
0.28 |
chr14_76798634_76798966 | 3.48 |
Gm30246 |
predicted gene, 30246 |
17973 |
0.17 |
chr4_76964763_76964914 | 3.48 |
Gm23159 |
predicted gene, 23159 |
6340 |
0.27 |
chr2_32525017_32525309 | 3.48 |
Gm13412 |
predicted gene 13412 |
132 |
0.92 |
chr3_18210346_18210497 | 3.48 |
Gm23686 |
predicted gene, 23686 |
32796 |
0.17 |
chr7_79758727_79758926 | 3.47 |
Wdr93 |
WD repeat domain 93 |
15663 |
0.08 |
chr13_111488300_111488451 | 3.47 |
Gpbp1 |
GC-rich promoter binding protein 1 |
663 |
0.7 |
chr10_108431934_108432221 | 3.47 |
Gm25591 |
predicted gene, 25591 |
4010 |
0.22 |
chr7_98355230_98355493 | 3.46 |
Tsku |
tsukushi, small leucine rich proteoglycan |
4718 |
0.19 |
chr6_136906748_136907166 | 3.46 |
Erp27 |
endoplasmic reticulum protein 27 |
15183 |
0.11 |
chr13_96742797_96742948 | 3.46 |
Ankrd31 |
ankyrin repeat domain 31 |
5400 |
0.2 |
chrX_98148456_98149039 | 3.46 |
Ar |
androgen receptor |
22 |
0.99 |
chr4_76366510_76366724 | 3.46 |
Ptprd |
protein tyrosine phosphatase, receptor type, D |
22374 |
0.21 |
chr7_29211431_29211967 | 3.45 |
Catsperg1 |
cation channel sperm associated auxiliary subunit gamma 1 |
204 |
0.86 |
chr9_94016628_94017010 | 3.45 |
Gm5369 |
predicted gene 5369 |
122643 |
0.06 |
chr3_18143898_18144049 | 3.44 |
Gm23686 |
predicted gene, 23686 |
33652 |
0.17 |
chr6_136894571_136894922 | 3.44 |
Mgp |
matrix Gla protein |
18923 |
0.1 |
chr3_95322811_95323271 | 3.43 |
Cers2 |
ceramide synthase 2 |
2101 |
0.14 |
chr1_75010536_75010846 | 3.43 |
Nhej1 |
non-homologous end joining factor 1 |
35948 |
0.1 |
chr8_105087174_105087570 | 3.43 |
Ces3b |
carboxylesterase 3B |
1247 |
0.3 |
chr1_67152094_67152459 | 3.42 |
Cps1 |
carbamoyl-phosphate synthetase 1 |
29250 |
0.19 |
chr13_82200174_82200343 | 3.42 |
Gm48155 |
predicted gene, 48155 |
110501 |
0.07 |
chr19_40174636_40174787 | 3.41 |
Cyp2c70 |
cytochrome P450, family 2, subfamily c, polypeptide 70 |
12575 |
0.15 |
chr7_119965208_119965675 | 3.41 |
Dnah3 |
dynein, axonemal, heavy chain 3 |
2401 |
0.24 |
chr4_102806758_102806909 | 3.39 |
Sgip1 |
SH3-domain GRB2-like (endophilin) interacting protein 1 |
46308 |
0.16 |
chr3_133759501_133760150 | 3.39 |
Gm6135 |
prediticted gene 6135 |
31679 |
0.18 |
chr3_32563174_32563674 | 3.39 |
Mfn1 |
mitofusin 1 |
516 |
0.74 |
chr2_58765113_58765779 | 3.37 |
Upp2 |
uridine phosphorylase 2 |
121 |
0.97 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.2 | 27.7 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
7.7 | 46.3 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
6.5 | 19.5 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
6.1 | 18.4 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
5.3 | 21.0 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
5.1 | 15.4 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
4.9 | 9.8 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
4.7 | 18.7 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
4.0 | 12.1 | GO:0006068 | ethanol catabolic process(GO:0006068) |
3.9 | 15.7 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
3.9 | 15.4 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
3.5 | 10.6 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
3.5 | 10.5 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
3.2 | 3.2 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
3.0 | 15.0 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
3.0 | 8.9 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
2.9 | 8.7 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
2.8 | 8.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
2.8 | 31.0 | GO:0009404 | toxin metabolic process(GO:0009404) |
2.6 | 7.9 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
2.6 | 13.0 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
2.4 | 7.3 | GO:0021553 | olfactory nerve development(GO:0021553) |
2.4 | 16.8 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
2.3 | 7.0 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
2.1 | 8.5 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
2.1 | 12.5 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
2.1 | 18.7 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
2.0 | 6.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
2.0 | 8.0 | GO:0003383 | apical constriction(GO:0003383) |
1.9 | 5.8 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
1.9 | 7.7 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
1.9 | 5.7 | GO:0097167 | circadian regulation of translation(GO:0097167) |
1.9 | 7.6 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
1.9 | 13.2 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
1.8 | 5.5 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
1.8 | 5.4 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
1.8 | 5.4 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
1.8 | 5.4 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
1.7 | 13.9 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
1.7 | 5.1 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
1.7 | 5.0 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
1.6 | 4.9 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
1.6 | 4.8 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.6 | 4.8 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
1.6 | 4.8 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
1.6 | 6.3 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
1.6 | 6.3 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
1.5 | 3.1 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
1.5 | 4.5 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
1.5 | 1.5 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
1.5 | 6.0 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
1.5 | 4.5 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
1.5 | 13.4 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
1.5 | 3.0 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
1.5 | 4.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.5 | 2.9 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
1.5 | 1.5 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.4 | 1.4 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
1.4 | 5.7 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
1.4 | 4.3 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.4 | 7.2 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
1.4 | 5.7 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
1.4 | 5.7 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
1.4 | 7.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
1.4 | 2.8 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
1.4 | 1.4 | GO:1903297 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
1.4 | 4.2 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
1.4 | 5.5 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
1.4 | 2.7 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
1.4 | 8.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
1.3 | 10.7 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
1.3 | 5.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
1.3 | 6.5 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
1.3 | 3.9 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
1.3 | 2.6 | GO:0046271 | phenylpropanoid metabolic process(GO:0009698) phenylpropanoid catabolic process(GO:0046271) |
1.2 | 6.2 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
1.2 | 3.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
1.2 | 4.9 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
1.2 | 1.2 | GO:0061724 | lipophagy(GO:0061724) |
1.2 | 7.2 | GO:0015074 | DNA integration(GO:0015074) |
1.2 | 3.6 | GO:0000050 | urea cycle(GO:0000050) |
1.2 | 14.4 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
1.2 | 2.4 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
1.2 | 1.2 | GO:0003160 | endocardium morphogenesis(GO:0003160) |
1.2 | 34.4 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
1.2 | 1.2 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
1.2 | 3.5 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
1.2 | 3.5 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
1.2 | 2.3 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
1.2 | 3.5 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
1.1 | 1.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
1.1 | 5.7 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
1.1 | 3.4 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
1.1 | 1.1 | GO:0070827 | chromatin maintenance(GO:0070827) |
1.1 | 6.8 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
1.1 | 1.1 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
1.1 | 1.1 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
1.1 | 6.6 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
1.1 | 2.2 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
1.1 | 1.1 | GO:0002434 | immune complex clearance(GO:0002434) |
1.1 | 5.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
1.1 | 6.6 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
1.1 | 1.1 | GO:0043465 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
1.1 | 5.4 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
1.1 | 1.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
1.1 | 2.2 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
1.1 | 1.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
1.1 | 10.5 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
1.0 | 3.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
1.0 | 4.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
1.0 | 5.2 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.0 | 2.0 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
1.0 | 1.0 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
1.0 | 8.9 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
1.0 | 4.0 | GO:0048478 | replication fork protection(GO:0048478) |
1.0 | 3.0 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
1.0 | 5.9 | GO:0006559 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
1.0 | 3.0 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.0 | 6.8 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
1.0 | 1.0 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
1.0 | 1.9 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
1.0 | 2.9 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.0 | 3.9 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
1.0 | 1.9 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
1.0 | 2.9 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
1.0 | 1.9 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
1.0 | 3.8 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
1.0 | 1.9 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.9 | 1.9 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.9 | 1.9 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.9 | 6.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.9 | 4.7 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.9 | 1.9 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.9 | 1.9 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.9 | 2.8 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.9 | 14.7 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.9 | 0.9 | GO:1990874 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
0.9 | 5.5 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.9 | 2.7 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.9 | 3.7 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.9 | 3.6 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.9 | 4.6 | GO:2000794 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.9 | 2.7 | GO:0061010 | gall bladder development(GO:0061010) |
0.9 | 2.7 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.9 | 2.7 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.9 | 4.5 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.9 | 1.8 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.9 | 0.9 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.9 | 13.2 | GO:0017144 | drug metabolic process(GO:0017144) |
0.9 | 3.5 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.9 | 2.6 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.9 | 3.5 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.9 | 2.6 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.9 | 0.9 | GO:0045764 | positive regulation of cellular amino acid metabolic process(GO:0045764) |
0.9 | 1.7 | GO:0060956 | endocardial cell differentiation(GO:0060956) |
0.9 | 20.7 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.9 | 0.9 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.9 | 2.6 | GO:0035973 | aggrephagy(GO:0035973) |
0.9 | 2.6 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.9 | 2.6 | GO:0006562 | proline catabolic process(GO:0006562) |
0.9 | 1.7 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.9 | 8.5 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.9 | 0.9 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.8 | 2.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.8 | 4.2 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.8 | 5.7 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.8 | 8.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.8 | 1.6 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.8 | 2.4 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.8 | 1.6 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.8 | 1.6 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.8 | 4.0 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.8 | 2.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.8 | 0.8 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.8 | 4.8 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.8 | 0.8 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.8 | 2.4 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.8 | 2.4 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.8 | 2.3 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.8 | 7.0 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.8 | 0.8 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.8 | 2.3 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.8 | 3.1 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.8 | 1.5 | GO:0048371 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.8 | 2.3 | GO:0044857 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
0.8 | 2.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.8 | 2.3 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.8 | 6.9 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.8 | 0.8 | GO:1901524 | regulation of macromitophagy(GO:1901524) |
0.8 | 2.3 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.8 | 3.0 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.8 | 4.5 | GO:0060613 | fat pad development(GO:0060613) |
0.8 | 0.8 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
0.8 | 3.0 | GO:0015819 | lysine transport(GO:0015819) |
0.8 | 5.3 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.8 | 3.0 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.7 | 8.2 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.7 | 5.2 | GO:0006265 | DNA topological change(GO:0006265) |
0.7 | 3.0 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.7 | 5.2 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.7 | 0.7 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.7 | 2.9 | GO:0035627 | ceramide transport(GO:0035627) |
0.7 | 2.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.7 | 3.7 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.7 | 2.2 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.7 | 0.7 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.7 | 1.4 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.7 | 0.7 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.7 | 0.7 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.7 | 6.4 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.7 | 1.4 | GO:0060166 | olfactory pit development(GO:0060166) |
0.7 | 2.8 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.7 | 2.1 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.7 | 2.1 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.7 | 2.1 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.7 | 2.8 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.7 | 1.4 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.7 | 2.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.7 | 0.7 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.7 | 1.4 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.7 | 2.7 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.7 | 2.0 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.7 | 0.7 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.7 | 1.3 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.7 | 0.7 | GO:0061205 | paramesonephric duct development(GO:0061205) |
0.7 | 9.3 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.7 | 2.0 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.7 | 2.7 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.7 | 1.3 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.7 | 0.7 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.7 | 2.6 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.7 | 2.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.7 | 2.0 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.6 | 1.3 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.6 | 7.8 | GO:0006465 | signal peptide processing(GO:0006465) |
0.6 | 1.3 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.6 | 1.3 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.6 | 1.3 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.6 | 2.6 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.6 | 1.9 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.6 | 0.6 | GO:1903671 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) negative regulation of sprouting angiogenesis(GO:1903671) |
0.6 | 4.5 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.6 | 1.9 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.6 | 1.3 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.6 | 1.3 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.6 | 0.6 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.6 | 6.3 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.6 | 3.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.6 | 7.5 | GO:0045056 | transcytosis(GO:0045056) |
0.6 | 0.6 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.6 | 11.8 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.6 | 5.6 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.6 | 2.5 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.6 | 3.1 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.6 | 4.3 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.6 | 1.8 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.6 | 1.2 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.6 | 1.8 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.6 | 0.6 | GO:0031497 | chromatin assembly(GO:0031497) |
0.6 | 1.2 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.6 | 1.8 | GO:0046112 | nucleobase biosynthetic process(GO:0046112) |
0.6 | 2.4 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.6 | 2.4 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.6 | 1.2 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.6 | 2.4 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.6 | 1.2 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.6 | 1.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.6 | 0.6 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.6 | 1.2 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.6 | 1.2 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
0.6 | 0.6 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.6 | 2.4 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.6 | 4.1 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.6 | 1.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.6 | 2.3 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.6 | 1.8 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.6 | 1.2 | GO:0015747 | urate transport(GO:0015747) |
0.6 | 0.6 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.6 | 1.2 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin biosynthetic process(GO:0032049) |
0.6 | 2.3 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.6 | 1.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.6 | 1.7 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.6 | 4.6 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.6 | 1.2 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.6 | 3.5 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.6 | 4.1 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.6 | 4.0 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.6 | 3.4 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.6 | 1.1 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
0.6 | 1.7 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.6 | 1.7 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.6 | 1.7 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.6 | 2.3 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.6 | 10.7 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.6 | 1.7 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.6 | 1.7 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.6 | 0.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.6 | 1.7 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.6 | 1.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.6 | 3.3 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.6 | 4.4 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.6 | 5.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.6 | 0.6 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.6 | 6.6 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.6 | 1.7 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.5 | 2.7 | GO:0015867 | ATP transport(GO:0015867) |
0.5 | 2.2 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.5 | 2.7 | GO:0015871 | choline transport(GO:0015871) |
0.5 | 1.6 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.5 | 1.6 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.5 | 15.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.5 | 2.2 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.5 | 1.6 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.5 | 3.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.5 | 1.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.5 | 3.8 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.5 | 2.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.5 | 1.6 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.5 | 0.5 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.5 | 2.7 | GO:0008354 | germ cell migration(GO:0008354) |
0.5 | 2.1 | GO:0046618 | drug export(GO:0046618) |
0.5 | 0.5 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.5 | 0.5 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.5 | 1.6 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.5 | 2.6 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.5 | 0.5 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.5 | 2.1 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.5 | 1.0 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.5 | 0.5 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.5 | 1.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.5 | 1.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.5 | 9.3 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.5 | 1.5 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.5 | 1.0 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.5 | 2.1 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.5 | 1.5 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.5 | 0.5 | GO:1904833 | positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of removal of superoxide radicals(GO:1904833) |
0.5 | 3.1 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.5 | 0.5 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.5 | 1.5 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.5 | 3.0 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.5 | 1.0 | GO:0045991 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite activation of transcription(GO:0045991) |
0.5 | 4.0 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.5 | 1.0 | GO:0060594 | mammary gland specification(GO:0060594) |
0.5 | 1.0 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.5 | 4.0 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.5 | 3.0 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.5 | 1.0 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.5 | 1.5 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.5 | 1.0 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.5 | 1.0 | GO:0030035 | microspike assembly(GO:0030035) |
0.5 | 2.0 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.5 | 3.0 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.5 | 1.0 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.5 | 2.0 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.5 | 4.9 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.5 | 1.5 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.5 | 2.5 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.5 | 2.0 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.5 | 0.5 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
0.5 | 3.9 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.5 | 8.3 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.5 | 6.3 | GO:0045116 | protein neddylation(GO:0045116) |
0.5 | 3.9 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.5 | 1.9 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.5 | 1.5 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.5 | 1.0 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.5 | 1.4 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.5 | 0.5 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) |
0.5 | 1.4 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.5 | 3.3 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.5 | 2.4 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.5 | 1.4 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.5 | 0.5 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.5 | 0.5 | GO:0061316 | canonical Wnt signaling pathway involved in heart development(GO:0061316) |
0.5 | 1.4 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.5 | 0.9 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.5 | 3.7 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.5 | 2.8 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.5 | 0.9 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.5 | 0.5 | GO:0002215 | defense response to nematode(GO:0002215) |
0.5 | 11.6 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.5 | 0.5 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.5 | 0.9 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.5 | 0.5 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.5 | 3.2 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.5 | 0.9 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.5 | 1.4 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.5 | 0.5 | GO:0035799 | ureter maturation(GO:0035799) |
0.5 | 1.4 | GO:0030576 | Cajal body organization(GO:0030576) |
0.5 | 2.3 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.5 | 1.8 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.5 | 0.9 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.5 | 0.9 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.5 | 2.7 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.5 | 2.3 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.5 | 0.5 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.5 | 1.8 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.5 | 2.3 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.4 | 2.2 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.4 | 1.3 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.4 | 5.4 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.4 | 0.9 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.4 | 0.9 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.4 | 1.8 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.4 | 2.2 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.4 | 0.9 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.4 | 2.6 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.4 | 1.3 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.4 | 0.9 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.4 | 2.2 | GO:0022605 | oogenesis stage(GO:0022605) |
0.4 | 1.3 | GO:0048102 | autophagic cell death(GO:0048102) |
0.4 | 2.2 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.4 | 2.6 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.4 | 1.3 | GO:0048254 | snoRNA localization(GO:0048254) |
0.4 | 8.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.4 | 3.0 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.4 | 12.6 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.4 | 2.2 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.4 | 1.7 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
0.4 | 0.4 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.4 | 2.6 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.4 | 0.9 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.4 | 2.2 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.4 | 0.9 | GO:1902226 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
0.4 | 0.4 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.4 | 5.6 | GO:0051923 | sulfation(GO:0051923) |
0.4 | 1.3 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.4 | 3.9 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.4 | 2.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.4 | 0.9 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.4 | 0.4 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.4 | 1.7 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.4 | 2.6 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.4 | 10.2 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.4 | 0.9 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.4 | 1.7 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.4 | 1.3 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.4 | 2.5 | GO:0010984 | regulation of lipoprotein particle clearance(GO:0010984) |
0.4 | 1.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.4 | 0.8 | GO:0032202 | telomere assembly(GO:0032202) |
0.4 | 1.3 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.4 | 0.8 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.4 | 2.9 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.4 | 6.7 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.4 | 0.8 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.4 | 2.1 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.4 | 0.8 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.4 | 4.6 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.4 | 1.2 | GO:0061009 | common bile duct development(GO:0061009) |
0.4 | 0.8 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.4 | 2.5 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.4 | 0.4 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.4 | 1.2 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.4 | 0.4 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.4 | 1.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.4 | 2.9 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.4 | 3.7 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.4 | 2.0 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.4 | 0.8 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.4 | 0.4 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.4 | 2.0 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.4 | 0.8 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.4 | 3.2 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.4 | 2.4 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.4 | 0.8 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.4 | 0.8 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.4 | 0.8 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.4 | 0.4 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.4 | 2.8 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.4 | 2.0 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.4 | 0.8 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.4 | 0.8 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.4 | 4.7 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.4 | 1.6 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.4 | 0.4 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) positive regulation of glucose mediated signaling pathway(GO:1902661) |
0.4 | 14.2 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.4 | 1.6 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.4 | 0.4 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.4 | 0.4 | GO:2000347 | positive regulation of hepatocyte proliferation(GO:2000347) |
0.4 | 1.2 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.4 | 6.7 | GO:0030488 | tRNA methylation(GO:0030488) |
0.4 | 0.8 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.4 | 2.4 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.4 | 0.4 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.4 | 0.4 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.4 | 1.2 | GO:0008355 | olfactory learning(GO:0008355) |
0.4 | 1.2 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.4 | 0.8 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.4 | 1.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.4 | 0.8 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.4 | 3.1 | GO:0045176 | apical protein localization(GO:0045176) |
0.4 | 1.9 | GO:0019740 | nitrogen utilization(GO:0019740) |
0.4 | 2.3 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.4 | 0.4 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.4 | 3.8 | GO:0010165 | response to X-ray(GO:0010165) |
0.4 | 1.1 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.4 | 0.8 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.4 | 3.0 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.4 | 4.5 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.4 | 1.5 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.4 | 1.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.4 | 3.7 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.4 | 0.7 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.4 | 1.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.4 | 1.9 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.4 | 1.1 | GO:0002784 | regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
0.4 | 0.4 | GO:0061511 | centriole elongation(GO:0061511) |
0.4 | 0.4 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.4 | 0.4 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.4 | 3.3 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.4 | 0.4 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.4 | 0.4 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.4 | 0.7 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.4 | 1.1 | GO:0032439 | endosome localization(GO:0032439) |
0.4 | 0.4 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.4 | 0.4 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.4 | 3.3 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.4 | 0.4 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.4 | 2.9 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.4 | 4.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.4 | 3.9 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.4 | 1.4 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.4 | 2.1 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.4 | 0.7 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.4 | 1.4 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.4 | 0.7 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.4 | 0.7 | GO:1902075 | cellular response to salt(GO:1902075) |
0.4 | 2.8 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.4 | 2.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.4 | 1.4 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.4 | 0.7 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.4 | 0.4 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.4 | 1.4 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.4 | 1.4 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.4 | 1.4 | GO:2000209 | regulation of anoikis(GO:2000209) |
0.4 | 3.5 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.4 | 8.4 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.4 | 2.1 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.4 | 3.2 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.4 | 1.8 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.3 | 1.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.3 | 1.7 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.3 | 0.3 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.3 | 2.8 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.3 | 1.0 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.3 | 1.0 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.3 | 11.4 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.3 | 2.4 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.3 | 2.1 | GO:0042026 | protein refolding(GO:0042026) |
0.3 | 0.3 | GO:0072173 | metanephric tubule morphogenesis(GO:0072173) |
0.3 | 1.4 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.3 | 4.8 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.3 | 1.0 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.3 | 0.3 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.3 | 1.7 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.3 | 0.3 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.3 | 0.7 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.3 | 4.8 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 5.1 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.3 | 1.0 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.3 | 0.3 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.3 | 2.4 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.3 | 1.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 3.4 | GO:0060487 | lung epithelial cell differentiation(GO:0060487) |
0.3 | 1.3 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.3 | 0.7 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.3 | 0.3 | GO:0090399 | replicative senescence(GO:0090399) |
0.3 | 1.0 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.3 | 1.0 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.3 | 1.3 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.3 | 0.3 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.3 | 1.3 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
0.3 | 0.3 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.3 | 1.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.3 | 0.7 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.3 | 1.0 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.3 | 0.3 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.3 | 0.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.3 | 0.7 | GO:1903313 | positive regulation of mRNA metabolic process(GO:1903313) |
0.3 | 1.6 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.3 | 0.3 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
0.3 | 0.7 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.3 | 1.6 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.3 | 0.6 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.3 | 0.6 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.3 | 0.3 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.3 | 0.3 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.3 | 6.8 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.3 | 1.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.3 | 0.6 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.3 | 2.6 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.3 | 0.3 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.3 | 3.5 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.3 | 1.0 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.3 | 0.3 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.3 | 2.2 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.3 | 4.2 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.3 | 3.2 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.3 | 1.0 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.3 | 0.6 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.3 | 0.9 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.3 | 1.6 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.3 | 1.6 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.3 | 2.8 | GO:0001967 | suckling behavior(GO:0001967) |
0.3 | 3.5 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.3 | 1.3 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.3 | 2.8 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.3 | 0.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.3 | 0.9 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.3 | 1.6 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.3 | 1.9 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.3 | 4.4 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.3 | 0.6 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.3 | 0.9 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.3 | 4.4 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.3 | 1.2 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.3 | 0.6 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.3 | 13.3 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.3 | 1.5 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.3 | 13.6 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.3 | 2.8 | GO:1901070 | guanosine-containing compound biosynthetic process(GO:1901070) |
0.3 | 0.3 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.3 | 0.6 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.3 | 1.5 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.3 | 1.8 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.3 | 0.6 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.3 | 2.1 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.3 | 0.3 | GO:0006116 | NADH oxidation(GO:0006116) |
0.3 | 0.6 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.3 | 2.7 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.3 | 0.6 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.3 | 2.7 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.3 | 1.2 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.3 | 1.5 | GO:1904970 | brush border assembly(GO:1904970) |
0.3 | 0.3 | GO:0006971 | hypotonic response(GO:0006971) |
0.3 | 0.9 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 0.6 | GO:0051584 | regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
0.3 | 0.9 | GO:0070341 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
0.3 | 0.9 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.3 | 2.3 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.3 | 1.2 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.3 | 0.6 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.3 | 0.3 | GO:0002339 | B cell selection(GO:0002339) |
0.3 | 0.6 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.3 | 2.0 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.3 | 0.6 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.3 | 0.3 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.3 | 0.6 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.3 | 0.3 | GO:1904478 | regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
0.3 | 2.3 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.3 | 0.6 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.3 | 0.3 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.3 | 2.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.3 | 0.9 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.3 | 1.1 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.3 | 1.4 | GO:0051639 | actin filament network formation(GO:0051639) |
0.3 | 0.6 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.3 | 2.5 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.3 | 0.8 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.3 | 3.6 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.3 | 1.4 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.3 | 1.1 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.3 | 0.6 | GO:0090427 | activation of meiosis(GO:0090427) |
0.3 | 0.6 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.3 | 1.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.3 | 1.4 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.3 | 0.3 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.3 | 2.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.3 | 0.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.3 | 0.3 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.3 | 0.3 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.3 | 0.6 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.3 | 3.8 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.3 | 0.3 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.3 | 1.1 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.3 | 4.6 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.3 | 0.5 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.3 | 0.8 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.3 | 0.8 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.3 | 0.8 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 2.4 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.3 | 1.6 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.3 | 0.8 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.3 | 1.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.3 | 0.5 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.3 | 1.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.3 | 0.5 | GO:0032516 | positive regulation of phosphatase activity(GO:0010922) positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.3 | 0.8 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.3 | 1.9 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.3 | 1.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.3 | 0.8 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.3 | 5.5 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.3 | 1.8 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.3 | 3.7 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.3 | 1.8 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.3 | 0.8 | GO:0046959 | habituation(GO:0046959) |
0.3 | 1.0 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.3 | 5.8 | GO:0006400 | tRNA modification(GO:0006400) |
0.3 | 0.5 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.3 | 0.5 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.3 | 1.0 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.3 | 0.5 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.3 | 0.8 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.3 | 0.5 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.3 | 0.3 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.3 | 0.3 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.3 | 0.8 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.3 | 0.3 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.3 | 0.3 | GO:0035482 | gastric motility(GO:0035482) |
0.3 | 0.3 | GO:0046036 | CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
0.3 | 6.3 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.3 | 1.5 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.3 | 0.3 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.3 | 8.3 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.3 | 0.8 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.3 | 1.0 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.3 | 0.8 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.3 | 0.5 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.2 | 0.2 | GO:1903726 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) negative regulation of phospholipid metabolic process(GO:1903726) |
0.2 | 0.7 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 0.2 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.2 | 0.5 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.2 | 1.7 | GO:0015824 | proline transport(GO:0015824) |
0.2 | 0.7 | GO:0021898 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.2 | 0.2 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.2 | 2.0 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 2.5 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.2 | 0.2 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.2 | 1.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.2 | 0.5 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.2 | 4.7 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.2 | 0.2 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.2 | 0.5 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.2 | 0.5 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.2 | 1.0 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.2 | 1.7 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 2.9 | GO:0007099 | centriole replication(GO:0007099) |
0.2 | 1.5 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.2 | 1.0 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.5 | GO:0009650 | UV protection(GO:0009650) |
0.2 | 4.1 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 0.2 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.2 | 1.0 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.2 | 0.2 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.2 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 0.5 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.2 | 1.4 | GO:0006903 | vesicle targeting(GO:0006903) |
0.2 | 0.7 | GO:0002190 | cap-independent translational initiation(GO:0002190) IRES-dependent translational initiation(GO:0002192) |
0.2 | 1.9 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 0.7 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.2 | 0.2 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.2 | 0.9 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.2 | 0.2 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.2 | 0.2 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.2 | 3.6 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.2 | 0.9 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.2 | 0.2 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.2 | 1.6 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.2 | 0.9 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.2 | 0.5 | GO:0006573 | valine metabolic process(GO:0006573) |
0.2 | 0.2 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.2 | 0.9 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.2 | 0.5 | GO:0015677 | copper ion import(GO:0015677) |
0.2 | 0.2 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.2 | 1.2 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.2 | 0.9 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.2 | 0.5 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.2 | 0.2 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.2 | 1.4 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.2 | 1.4 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.2 | 2.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.2 | 0.9 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.2 | 0.9 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 0.5 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.2 | 0.5 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.2 | 0.2 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.2 | 0.5 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.2 | 2.5 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.2 | 5.0 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.2 | 1.8 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 0.9 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.2 | 2.5 | GO:1990403 | embryonic brain development(GO:1990403) |
0.2 | 0.2 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.2 | 0.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 0.9 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.2 | 0.2 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.2 | 0.2 | GO:0018214 | protein carboxylation(GO:0018214) |
0.2 | 0.2 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.2 | 0.9 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.2 | 5.0 | GO:0048240 | sperm capacitation(GO:0048240) |
0.2 | 0.4 | GO:0032252 | secretory granule localization(GO:0032252) |
0.2 | 0.7 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 0.2 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.2 | 0.4 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.2 | 1.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 0.2 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.2 | 0.9 | GO:0016074 | snoRNA metabolic process(GO:0016074) |
0.2 | 0.4 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.2 | 1.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.2 | 0.4 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.2 | 0.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 0.2 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.2 | 1.3 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.2 | 1.7 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.2 | 0.4 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.2 | 1.5 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.2 | 0.8 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.2 | 0.6 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.2 | 0.2 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.2 | 1.0 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.2 | 0.2 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.2 | 0.6 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.2 | 2.5 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 0.2 | GO:0021764 | amygdala development(GO:0021764) |
0.2 | 0.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 0.6 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.2 | 0.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.2 | 0.2 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.2 | 0.6 | GO:0016093 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.2 | 0.2 | GO:0002568 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.2 | 0.6 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 0.8 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.2 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.2 | 5.1 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.2 | 1.6 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.2 | 0.2 | GO:0043366 | beta selection(GO:0043366) |
0.2 | 0.2 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.2 | 0.2 | GO:0019230 | proprioception(GO:0019230) |
0.2 | 0.8 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.2 | 3.6 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.2 | 0.4 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.2 | 0.2 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.2 | 0.8 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.2 | 1.4 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 0.4 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.2 | 0.6 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.2 | 0.8 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.2 | 1.2 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.2 | 0.4 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.2 | 0.2 | GO:0090656 | t-circle formation(GO:0090656) |
0.2 | 1.6 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.2 | 0.2 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.2 | 1.8 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.2 | 0.6 | GO:0003266 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) regulation of secondary heart field cardioblast proliferation(GO:0003266) positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.2 | 1.2 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.2 | 0.6 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 2.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 0.2 | GO:0046471 | phosphatidylglycerol metabolic process(GO:0046471) |
0.2 | 0.6 | GO:0080009 | mRNA methylation(GO:0080009) |
0.2 | 9.4 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.2 | 2.1 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.2 | 5.1 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.2 | 0.8 | GO:0043174 | nucleoside salvage(GO:0043174) |
0.2 | 0.2 | GO:0032352 | positive regulation of hormone metabolic process(GO:0032352) |
0.2 | 0.2 | GO:0014891 | skeletal muscle atrophy(GO:0014732) striated muscle atrophy(GO:0014891) |
0.2 | 0.6 | GO:0042117 | monocyte activation(GO:0042117) |
0.2 | 0.6 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.2 | 2.9 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.2 | 1.6 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.2 | 1.7 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.2 | 1.4 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.2 | 1.2 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.2 | 0.4 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.2 | 0.4 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.2 | 0.8 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.2 | 1.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.2 | 0.6 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.2 | 0.6 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.2 | 0.2 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.2 | 2.7 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.2 | 1.1 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.2 | 0.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 0.4 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.2 | 0.4 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.2 | 0.4 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.2 | 0.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.2 | 0.8 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.2 | 0.4 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.2 | 0.4 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.2 | 0.4 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.2 | 0.2 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.2 | 1.3 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.2 | 0.2 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.2 | 0.9 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 1.7 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 2.8 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.2 | 4.8 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.2 | 0.7 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.2 | 0.2 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.2 | 1.3 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 0.4 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.2 | 0.4 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.2 | 0.4 | GO:0048596 | embryonic camera-type eye morphogenesis(GO:0048596) |
0.2 | 0.7 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) regulation of NADP metabolic process(GO:1902031) |
0.2 | 0.7 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.2 | 0.9 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.2 | 0.2 | GO:0070141 | response to UV-A(GO:0070141) |
0.2 | 1.8 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.2 | 3.6 | GO:0034605 | cellular response to heat(GO:0034605) |
0.2 | 0.4 | GO:1903299 | regulation of glucokinase activity(GO:0033131) regulation of hexokinase activity(GO:1903299) |
0.2 | 0.2 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.2 | 0.5 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.2 | 1.3 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.2 | 0.5 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.2 | 0.5 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.2 | 0.4 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.2 | 0.7 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.2 | 1.1 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.2 | 0.4 | GO:0019359 | NADP biosynthetic process(GO:0006741) nicotinamide nucleotide biosynthetic process(GO:0019359) |
0.2 | 0.9 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.2 | 0.9 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.2 | 0.5 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.2 | 2.6 | GO:0070542 | response to fatty acid(GO:0070542) |
0.2 | 2.4 | GO:0030431 | sleep(GO:0030431) |
0.2 | 0.2 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.2 | 0.5 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.2 | 0.3 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.2 | 5.5 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.2 | 1.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 0.2 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.2 | 0.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 0.5 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.2 | 0.3 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.2 | 0.3 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.2 | 0.3 | GO:0070842 | aggresome assembly(GO:0070842) |
0.2 | 0.2 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.2 | 0.5 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.2 | 0.3 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.2 | 0.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 0.2 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.2 | 0.3 | GO:0019081 | viral translation(GO:0019081) viral translational termination-reinitiation(GO:0075525) |
0.2 | 0.3 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.2 | 0.5 | GO:0002067 | glandular epithelial cell differentiation(GO:0002067) |
0.2 | 0.2 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.2 | 1.2 | GO:0000154 | rRNA modification(GO:0000154) |
0.2 | 0.3 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.2 | 1.0 | GO:0098586 | cellular response to virus(GO:0098586) |
0.2 | 0.7 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.2 | 0.3 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.2 | 0.5 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.2 | 0.2 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.2 | 0.2 | GO:0007567 | parturition(GO:0007567) |
0.2 | 0.3 | GO:0044805 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.2 | 0.2 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.2 | 0.5 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.2 | 0.2 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.2 | 0.5 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.2 | 0.2 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.2 | 0.3 | GO:0003181 | atrioventricular valve development(GO:0003171) atrioventricular valve morphogenesis(GO:0003181) |
0.2 | 0.5 | GO:0030878 | thyroid gland development(GO:0030878) |
0.2 | 0.2 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
0.2 | 0.2 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) viral latency(GO:0019042) |
0.2 | 0.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.2 | 0.3 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.2 | 0.5 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.2 | 0.8 | GO:0010898 | regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
0.2 | 0.2 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.2 | 0.2 | GO:0009301 | snRNA transcription(GO:0009301) |
0.2 | 0.6 | GO:0043243 | positive regulation of protein complex disassembly(GO:0043243) |
0.2 | 0.5 | GO:0009414 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.2 | 6.6 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.2 | 0.8 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.2 | 0.8 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.2 | 0.5 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 0.5 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 0.2 | GO:2001271 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.2 | 0.2 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.2 | 0.6 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.2 | 0.6 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.2 | 0.2 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.2 | 0.3 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.2 | 2.4 | GO:2000756 | regulation of peptidyl-lysine acetylation(GO:2000756) |
0.2 | 0.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.2 | 1.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 0.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 0.8 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.9 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 1.6 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.6 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 0.1 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.1 | 0.9 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 0.1 | GO:0050746 | regulation of lipoprotein metabolic process(GO:0050746) |
0.1 | 1.0 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 0.1 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 0.4 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 0.6 | GO:0042711 | maternal behavior(GO:0042711) |
0.1 | 0.4 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.7 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 1.5 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.1 | 1.2 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 4.0 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 4.5 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 0.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.4 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.1 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.1 | 2.3 | GO:0046324 | regulation of glucose import(GO:0046324) |
0.1 | 0.6 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.3 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.6 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.3 | GO:0070662 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.1 | 0.3 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.1 | 0.6 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.1 | 0.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.3 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.3 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 1.0 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.1 | 1.1 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.8 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.1 | 2.6 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.1 | 0.7 | GO:0022900 | electron transport chain(GO:0022900) |
0.1 | 0.8 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.1 | 0.8 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.3 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.1 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.1 | 0.5 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.8 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
0.1 | 0.8 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.4 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 1.2 | GO:0035094 | response to nicotine(GO:0035094) |
0.1 | 0.8 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.1 | 2.3 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 1.6 | GO:0048665 | neuron fate specification(GO:0048665) |
0.1 | 0.9 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.8 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.1 | 0.1 | GO:1901163 | regulation of trophoblast cell migration(GO:1901163) |
0.1 | 0.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.7 | GO:0060966 | regulation of posttranscriptional gene silencing(GO:0060147) regulation of gene silencing by RNA(GO:0060966) |
0.1 | 0.7 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.1 | 1.6 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.4 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 0.3 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.3 | GO:0006304 | DNA modification(GO:0006304) |
0.1 | 0.3 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.6 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.1 | 0.1 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 0.1 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 1.3 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.1 | 0.3 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.9 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.1 | 0.2 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.1 | 0.2 | GO:0048048 | embryonic eye morphogenesis(GO:0048048) |
0.1 | 0.5 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.1 | 0.2 | GO:0002576 | platelet degranulation(GO:0002576) |
0.1 | 0.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.2 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 1.1 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 1.9 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 1.2 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.1 | 1.3 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.2 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.5 | GO:0071435 | potassium ion export(GO:0071435) |
0.1 | 0.5 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.5 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.1 | 0.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.8 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.2 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.5 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.5 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 0.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 3.6 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 2.0 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 1.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 2.2 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.1 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.1 | 0.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 5.2 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.1 | 0.7 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.2 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.1 | 0.2 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.1 | 1.1 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.8 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 1.3 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.6 | GO:0009084 | glutamine family amino acid biosynthetic process(GO:0009084) |
0.1 | 2.4 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.1 | 0.2 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.1 | 0.1 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 1.1 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.1 | 0.4 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 0.1 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.1 | 0.2 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.4 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 0.5 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.1 | 1.3 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.1 | 0.6 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.1 | 0.3 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.1 | 0.9 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.4 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 0.3 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
0.1 | 0.3 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.5 | GO:0002931 | response to ischemia(GO:0002931) |
0.1 | 1.3 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.1 | 0.3 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.4 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.5 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 2.0 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 1.4 | GO:0035690 | cellular response to drug(GO:0035690) |
0.1 | 0.2 | GO:0046416 | D-amino acid catabolic process(GO:0019478) D-amino acid metabolic process(GO:0046416) |
0.1 | 1.0 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 0.1 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.1 | 1.2 | GO:0009584 | detection of visible light(GO:0009584) |
0.1 | 0.3 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 1.6 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 0.3 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 1.8 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.4 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.1 | 0.3 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 0.2 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.1 | 0.2 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.1 | 0.5 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.1 | 0.1 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 1.2 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.1 | 0.1 | GO:0060438 | trachea development(GO:0060438) |
0.1 | 0.1 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.1 | 0.1 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.4 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.1 | 0.3 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.1 | 0.4 | GO:0043584 | nose development(GO:0043584) |
0.1 | 0.6 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 0.5 | GO:0060074 | synapse maturation(GO:0060074) |
0.1 | 0.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.5 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.1 | 0.3 | GO:2000674 | regulation of type B pancreatic cell apoptotic process(GO:2000674) |
0.1 | 7.6 | GO:0006364 | rRNA processing(GO:0006364) |
0.1 | 0.2 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.1 | 0.6 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.3 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.1 | 0.4 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.1 | 0.3 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.5 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.1 | 0.1 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.1 | GO:0060525 | prostate glandular acinus development(GO:0060525) |
0.1 | 0.4 | GO:0001878 | response to yeast(GO:0001878) |
0.1 | 0.2 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 0.7 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 0.4 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.3 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.1 | 0.1 | GO:0032375 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) |
0.1 | 0.6 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 1.0 | GO:0007416 | synapse assembly(GO:0007416) |
0.1 | 0.3 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.1 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.1 | 0.3 | GO:0072395 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.1 | 0.2 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 0.2 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.3 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.6 | GO:0046939 | nucleotide phosphorylation(GO:0046939) |
0.1 | 0.3 | GO:1901020 | negative regulation of calcium ion transmembrane transporter activity(GO:1901020) |
0.1 | 0.6 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 2.7 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 0.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.7 | GO:0070988 | demethylation(GO:0070988) |
0.1 | 1.2 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 1.2 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.1 | 0.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.1 | GO:1903365 | regulation of fear response(GO:1903365) positive regulation of fear response(GO:1903367) regulation of behavioral fear response(GO:2000822) positive regulation of behavioral fear response(GO:2000987) |
0.1 | 0.1 | GO:0002778 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.1 | 0.4 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.1 | 0.1 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.1 | 0.4 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 4.9 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
0.1 | 0.6 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.1 | 0.2 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.2 | GO:0000087 | mitotic M phase(GO:0000087) |
0.1 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.1 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.2 | GO:0070922 | small RNA loading onto RISC(GO:0070922) |
0.1 | 0.2 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.1 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) |
0.1 | 0.2 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 1.0 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.1 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.1 | 0.4 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.4 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.1 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.1 | 0.5 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.1 | 0.8 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.6 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.4 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 0.5 | GO:0006337 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.2 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 1.0 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 1.0 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.1 | 0.7 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.1 | 0.6 | GO:0090505 | wound healing, spreading of cells(GO:0044319) epiboly involved in wound healing(GO:0090505) |
0.1 | 0.4 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.1 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.1 | 0.1 | GO:0043084 | penile erection(GO:0043084) |
0.1 | 0.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.1 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.1 | 5.1 | GO:0007286 | spermatid development(GO:0007286) |
0.1 | 0.4 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 0.1 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.1 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.1 | 0.1 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 0.3 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.1 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.1 | 0.1 | GO:0061525 | hindgut development(GO:0061525) |
0.1 | 0.3 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.1 | 0.3 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) |
0.1 | 0.1 | GO:0044036 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.1 | 0.6 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.1 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.8 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.1 | 1.6 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 0.1 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.7 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.1 | 0.1 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.1 | 0.1 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.1 | 0.3 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.1 | 2.1 | GO:0016052 | carbohydrate catabolic process(GO:0016052) |
0.1 | 0.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.9 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.1 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.1 | 1.1 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 0.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 0.3 | GO:0048515 | spermatid differentiation(GO:0048515) |
0.1 | 0.6 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.1 | 1.4 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.1 | 0.3 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.1 | 0.1 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 0.2 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 0.1 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.1 | 0.4 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.1 | 0.3 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.1 | 0.2 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.1 | 0.3 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.1 | GO:0006595 | polyamine metabolic process(GO:0006595) |
0.1 | 0.6 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.2 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 0.8 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.1 | 1.4 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.6 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.1 | 1.2 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.5 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.1 | 0.3 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 0.3 | GO:0097300 | programmed necrotic cell death(GO:0097300) |
0.1 | 0.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.1 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.1 | 0.2 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.1 | 0.1 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.2 | GO:0048538 | thymus development(GO:0048538) |
0.1 | 0.2 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.1 | 1.4 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.1 | 0.2 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.6 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.1 | 0.2 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.1 | 2.2 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 1.6 | GO:1903844 | regulation of transforming growth factor beta receptor signaling pathway(GO:0017015) regulation of cellular response to transforming growth factor beta stimulus(GO:1903844) |
0.1 | 0.1 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.1 | 0.1 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.1 | 0.2 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 1.3 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 0.1 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.1 | 0.1 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.1 | 0.1 | GO:0060746 | parental behavior(GO:0060746) |
0.1 | 0.7 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.1 | 0.3 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.1 | 0.6 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 1.1 | GO:0009411 | response to UV(GO:0009411) |
0.1 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.1 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.0 | 0.1 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.4 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.2 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.0 | 0.0 | GO:1900424 | regulation of defense response to bacterium(GO:1900424) |
0.0 | 0.0 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.1 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.0 | 0.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.6 | GO:0090102 | cochlea development(GO:0090102) |
0.0 | 0.0 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.0 | 0.4 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 0.1 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.0 | 0.0 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.0 | 0.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.2 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.0 | 0.3 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.0 | 0.0 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.0 | 4.0 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.0 | 0.1 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.0 | 0.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.0 | 0.7 | GO:0035966 | response to topologically incorrect protein(GO:0035966) |
0.0 | 0.0 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 0.2 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.2 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.0 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.0 | 0.0 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.0 | 0.4 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.4 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.3 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.1 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.0 | 0.0 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 1.6 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.0 | 0.0 | GO:1902866 | regulation of neural retina development(GO:0061074) regulation of retina development in camera-type eye(GO:1902866) |
0.0 | 0.1 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.0 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.0 | GO:0030070 | insulin processing(GO:0030070) |
0.0 | 0.1 | GO:0060416 | response to growth hormone(GO:0060416) |
0.0 | 4.6 | GO:0032259 | methylation(GO:0032259) |
0.0 | 0.6 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.0 | 0.0 | GO:0001927 | exocyst assembly(GO:0001927) |
0.0 | 0.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.1 | GO:0070305 | response to cGMP(GO:0070305) |
0.0 | 0.1 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.1 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.0 | GO:0060231 | mesenchymal to epithelial transition(GO:0060231) |
0.0 | 0.4 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.2 | GO:0051304 | chromosome separation(GO:0051304) |
0.0 | 0.0 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.0 | 0.9 | GO:0051168 | nuclear export(GO:0051168) |
0.0 | 0.1 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.0 | 0.0 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.0 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.0 | 0.0 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.0 | 0.0 | GO:0061526 | acetylcholine transport(GO:0015870) acetylcholine secretion(GO:0061526) acetate ester transport(GO:1901374) |
0.0 | 0.1 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.0 | 0.2 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.2 | GO:0051298 | centrosome duplication(GO:0051298) |
0.0 | 0.0 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.0 | 0.0 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.0 | 0.0 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.1 | GO:0046785 | microtubule polymerization(GO:0046785) |
0.0 | 0.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.0 | GO:0070243 | regulation of thymocyte apoptotic process(GO:0070243) negative regulation of thymocyte apoptotic process(GO:0070244) |
0.0 | 0.1 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.0 | 0.1 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.1 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.0 | 0.3 | GO:0040014 | regulation of multicellular organism growth(GO:0040014) |
0.0 | 0.8 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.4 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.0 | 0.3 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.0 | 0.1 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.0 | 0.1 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.1 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.0 | 0.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.3 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.4 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.0 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.0 | 0.0 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.0 | 0.0 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
0.0 | 0.5 | GO:0060538 | skeletal muscle organ development(GO:0060538) |
0.0 | 0.0 | GO:0010827 | regulation of glucose transport(GO:0010827) |
0.0 | 0.0 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.0 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.0 | 0.0 | GO:0001759 | organ induction(GO:0001759) developmental induction(GO:0031128) |
0.0 | 0.0 | GO:0090185 | negative regulation of kidney development(GO:0090185) |
0.0 | 0.0 | GO:0031054 | pre-miRNA processing(GO:0031054) |
0.0 | 0.4 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.0 | GO:0086068 | Purkinje myocyte action potential(GO:0086017) Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.0 | 0.0 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.4 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 1.4 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.0 | GO:0031050 | dsRNA fragmentation(GO:0031050) production of small RNA involved in gene silencing by RNA(GO:0070918) |
0.0 | 0.0 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.0 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.0 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.0 | 0.0 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.0 | 0.0 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.1 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.2 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.0 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.0 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.0 | 0.1 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
0.0 | 0.0 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.0 | 0.0 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.0 | 0.1 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.1 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.0 | 0.0 | GO:0021983 | pituitary gland development(GO:0021983) |
0.0 | 0.0 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.0 | 0.5 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.0 | 0.0 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.0 | 0.0 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.0 | 0.0 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.0 | 0.0 | GO:0071625 | vocalization behavior(GO:0071625) |
0.0 | 0.0 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.0 | 0.0 | GO:0008063 | Toll signaling pathway(GO:0008063) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.8 | 26.5 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
3.6 | 10.9 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
3.4 | 16.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
2.5 | 9.8 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
2.2 | 11.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
2.2 | 8.6 | GO:0044316 | cone cell pedicle(GO:0044316) |
1.9 | 21.0 | GO:0070852 | cell body fiber(GO:0070852) |
1.7 | 6.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
1.6 | 6.2 | GO:0045293 | mRNA editing complex(GO:0045293) |
1.5 | 7.4 | GO:0097433 | dense body(GO:0097433) |
1.4 | 4.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.3 | 3.9 | GO:0032444 | activin responsive factor complex(GO:0032444) |
1.3 | 3.8 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
1.3 | 6.4 | GO:0005579 | membrane attack complex(GO:0005579) |
1.3 | 10.2 | GO:0016342 | catenin complex(GO:0016342) |
1.2 | 4.7 | GO:0033269 | internode region of axon(GO:0033269) |
1.1 | 4.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
1.1 | 5.6 | GO:0031298 | replication fork protection complex(GO:0031298) |
1.0 | 12.6 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
1.0 | 16.7 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
1.0 | 3.0 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
1.0 | 2.9 | GO:0048179 | activin receptor complex(GO:0048179) |
0.9 | 2.7 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.9 | 10.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.9 | 2.7 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.9 | 15.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.9 | 2.6 | GO:0097413 | Lewy body(GO:0097413) |
0.9 | 2.6 | GO:0005955 | calcineurin complex(GO:0005955) |
0.9 | 3.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.8 | 2.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.8 | 4.6 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.8 | 3.8 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.8 | 3.0 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.7 | 2.2 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.7 | 14.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.7 | 13.3 | GO:0043034 | costamere(GO:0043034) |
0.7 | 6.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.7 | 0.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.7 | 10.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.7 | 3.6 | GO:0005915 | zonula adherens(GO:0005915) |
0.7 | 3.6 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.7 | 2.8 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.7 | 2.1 | GO:0005712 | chiasma(GO:0005712) |
0.7 | 4.2 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.7 | 5.6 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.7 | 5.5 | GO:0042587 | glycogen granule(GO:0042587) |
0.7 | 30.4 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.7 | 2.7 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.7 | 4.7 | GO:0045180 | basal cortex(GO:0045180) |
0.7 | 2.0 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.6 | 2.6 | GO:0045298 | tubulin complex(GO:0045298) |
0.6 | 1.9 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.6 | 3.7 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.6 | 6.5 | GO:0000346 | transcription export complex(GO:0000346) |
0.6 | 2.4 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.6 | 1.8 | GO:0097441 | basilar dendrite(GO:0097441) |
0.6 | 9.9 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.6 | 2.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.6 | 2.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.6 | 3.5 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.6 | 4.5 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.6 | 3.9 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.6 | 0.6 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.6 | 13.3 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.6 | 1.7 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.5 | 2.7 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.5 | 3.8 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.5 | 25.3 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.5 | 0.5 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.5 | 1.5 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.5 | 0.5 | GO:0055087 | Ski complex(GO:0055087) |
0.5 | 3.0 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.5 | 20.3 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.5 | 2.0 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.5 | 4.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.5 | 3.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.5 | 2.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.5 | 1.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.5 | 1.5 | GO:0005827 | polar microtubule(GO:0005827) |
0.5 | 0.5 | GO:0000785 | chromatin(GO:0000785) |
0.5 | 1.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.5 | 3.9 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.5 | 2.9 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.5 | 11.1 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.5 | 1.4 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.5 | 2.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.5 | 0.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.5 | 3.8 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.5 | 1.9 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.5 | 1.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.5 | 3.8 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.5 | 6.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.5 | 0.5 | GO:0031261 | GINS complex(GO:0000811) DNA replication preinitiation complex(GO:0031261) |
0.5 | 0.5 | GO:0097342 | ripoptosome(GO:0097342) |
0.4 | 0.4 | GO:0030118 | clathrin coat(GO:0030118) |
0.4 | 1.8 | GO:0030478 | actin cap(GO:0030478) |
0.4 | 2.7 | GO:0031415 | NatA complex(GO:0031415) |
0.4 | 1.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.4 | 1.3 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.4 | 4.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.4 | 2.2 | GO:0001940 | male pronucleus(GO:0001940) |
0.4 | 0.9 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.4 | 1.7 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.4 | 1.7 | GO:0035339 | SPOTS complex(GO:0035339) |
0.4 | 2.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.4 | 5.9 | GO:0010369 | chromocenter(GO:0010369) |
0.4 | 1.3 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.4 | 0.8 | GO:1990423 | RZZ complex(GO:1990423) |
0.4 | 1.7 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.4 | 1.3 | GO:0071942 | XPC complex(GO:0071942) |
0.4 | 2.1 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.4 | 3.8 | GO:0036128 | CatSper complex(GO:0036128) |
0.4 | 2.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.4 | 0.8 | GO:0070552 | BRISC complex(GO:0070552) |
0.4 | 1.6 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.4 | 2.9 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.4 | 38.6 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.4 | 1.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.4 | 2.4 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.4 | 1.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.4 | 1.6 | GO:0032021 | NELF complex(GO:0032021) |
0.4 | 1.6 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.4 | 1.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.4 | 3.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.4 | 2.3 | GO:0030686 | 90S preribosome(GO:0030686) |
0.4 | 0.8 | GO:0016589 | NURF complex(GO:0016589) |
0.4 | 1.5 | GO:0030891 | VCB complex(GO:0030891) |
0.4 | 1.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.4 | 2.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.4 | 1.5 | GO:0098536 | deuterosome(GO:0098536) |
0.4 | 1.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.4 | 2.6 | GO:0001650 | fibrillar center(GO:0001650) |
0.4 | 7.0 | GO:0005686 | U2 snRNP(GO:0005686) |
0.4 | 3.7 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.4 | 3.6 | GO:0032797 | SMN complex(GO:0032797) |
0.4 | 1.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.4 | 1.1 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.4 | 1.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.4 | 1.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.4 | 1.4 | GO:0071203 | WASH complex(GO:0071203) |
0.4 | 2.5 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.3 | 0.3 | GO:0045120 | pronucleus(GO:0045120) |
0.3 | 2.4 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.3 | 1.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.3 | 3.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.3 | 1.4 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.3 | 5.7 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.3 | 1.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.3 | 6.4 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.3 | 1.3 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.3 | 2.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 3.9 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 3.6 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.3 | 2.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 0.7 | GO:0034706 | sodium channel complex(GO:0034706) |
0.3 | 1.0 | GO:0070069 | cytochrome complex(GO:0070069) |
0.3 | 1.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.3 | 5.2 | GO:0002102 | podosome(GO:0002102) |
0.3 | 0.3 | GO:0001939 | female pronucleus(GO:0001939) |
0.3 | 1.3 | GO:0044308 | axonal spine(GO:0044308) |
0.3 | 0.3 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.3 | 6.2 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.3 | 1.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.3 | 0.9 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.3 | 2.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.3 | 1.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.3 | 2.7 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.3 | 1.8 | GO:0060170 | ciliary membrane(GO:0060170) |
0.3 | 0.6 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.3 | 0.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.3 | 5.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 3.5 | GO:0032426 | stereocilium tip(GO:0032426) |
0.3 | 10.3 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.3 | 1.5 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.3 | 1.2 | GO:0000938 | GARP complex(GO:0000938) |
0.3 | 6.6 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.3 | 0.6 | GO:0070013 | intracellular organelle lumen(GO:0070013) |
0.3 | 0.6 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.3 | 11.6 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.3 | 2.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.3 | 1.7 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.3 | 34.5 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.3 | 0.8 | GO:0072487 | MSL complex(GO:0072487) |
0.3 | 2.0 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.3 | 10.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.3 | 0.8 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.3 | 1.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 3.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.3 | 0.8 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.3 | 0.3 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.3 | 3.0 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.3 | 9.8 | GO:0030315 | T-tubule(GO:0030315) |
0.3 | 4.9 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.3 | 5.6 | GO:0031201 | SNARE complex(GO:0031201) |
0.3 | 4.8 | GO:0034451 | centriolar satellite(GO:0034451) |
0.3 | 0.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.3 | 1.3 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.3 | 0.3 | GO:0097452 | GAIT complex(GO:0097452) |
0.3 | 0.8 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.3 | 2.6 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.3 | 1.5 | GO:0030914 | STAGA complex(GO:0030914) |
0.3 | 2.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.3 | 4.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 0.5 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.3 | 1.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.3 | 0.5 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.3 | 1.8 | GO:1902911 | protein kinase complex(GO:1902911) |
0.3 | 1.0 | GO:1990130 | Iml1 complex(GO:1990130) |
0.3 | 6.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 6.7 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.2 | 0.7 | GO:0002177 | manchette(GO:0002177) |
0.2 | 2.5 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.2 | 1.2 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 2.0 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 22.7 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.2 | 1.7 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 1.5 | GO:0070187 | telosome(GO:0070187) |
0.2 | 0.7 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.2 | 3.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 0.7 | GO:0032437 | cuticular plate(GO:0032437) |
0.2 | 1.4 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.2 | 2.9 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 5.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.2 | 10.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.2 | 5.6 | GO:0031672 | A band(GO:0031672) |
0.2 | 1.6 | GO:0005839 | proteasome core complex(GO:0005839) |
0.2 | 0.9 | GO:0034704 | calcium channel complex(GO:0034704) |
0.2 | 1.2 | GO:0005688 | U6 snRNP(GO:0005688) |
0.2 | 0.5 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 2.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 3.9 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.2 | 0.5 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 0.7 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.2 | 1.4 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.2 | 0.4 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 2.2 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 2.9 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.2 | 1.3 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 1.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 0.9 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 1.3 | GO:0001652 | granular component(GO:0001652) |
0.2 | 1.1 | GO:0061617 | MICOS complex(GO:0061617) |
0.2 | 0.4 | GO:0071564 | npBAF complex(GO:0071564) |
0.2 | 224.9 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.2 | 0.6 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 0.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 4.6 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.2 | 0.4 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.2 | 0.4 | GO:0030894 | replisome(GO:0030894) |
0.2 | 2.7 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 1.6 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.2 | 11.0 | GO:0016605 | PML body(GO:0016605) |
0.2 | 0.8 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 1.0 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 3.0 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 0.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 0.8 | GO:0097422 | tubular endosome(GO:0097422) |
0.2 | 0.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.2 | 0.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.2 | 0.2 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.2 | 1.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.2 | 1.0 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 0.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 0.6 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 0.6 | GO:0032153 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.2 | 1.9 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.2 | 1.7 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 0.8 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 4.9 | GO:0032587 | ruffle membrane(GO:0032587) |
0.2 | 0.4 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 1.7 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.2 | 0.8 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.2 | 0.2 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.2 | 0.8 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.2 | 4.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 1.3 | GO:0036156 | inner dynein arm(GO:0036156) |
0.2 | 1.3 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 0.2 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.2 | 2.9 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.2 | 2.9 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 1.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 5.4 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 0.4 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.2 | 0.4 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.2 | 2.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 8.1 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 7.0 | GO:0005770 | late endosome(GO:0005770) |
0.2 | 7.4 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.2 | 0.7 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 3.3 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 7.3 | GO:0036126 | sperm flagellum(GO:0036126) |
0.2 | 0.2 | GO:0070695 | FHF complex(GO:0070695) |
0.2 | 1.0 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.2 | 1.5 | GO:0005652 | nuclear lamina(GO:0005652) |
0.2 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
0.2 | 13.7 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.2 | 1.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.2 | 5.7 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 4.5 | GO:0032040 | small-subunit processome(GO:0032040) |
0.2 | 2.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 2.3 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.2 | 1.0 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 0.7 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.2 | 0.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.2 | 17.8 | GO:0005769 | early endosome(GO:0005769) |
0.2 | 11.4 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.2 | 3.1 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 1.0 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 148.3 | GO:0005739 | mitochondrion(GO:0005739) |
0.2 | 4.2 | GO:0005901 | caveola(GO:0005901) |
0.2 | 10.2 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 2.7 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.2 | 0.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.2 | 0.6 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 2.5 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 1.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 1.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 3.2 | GO:0030496 | midbody(GO:0030496) |
0.2 | 5.2 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.2 | 1.5 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 0.8 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.2 | 6.3 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 7.8 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 11.0 | GO:0005874 | microtubule(GO:0005874) |
0.1 | 4.0 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 6.7 | GO:0005819 | spindle(GO:0005819) |
0.1 | 0.4 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 2.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.4 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.4 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 0.8 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.1 | 7.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 1.4 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 6.1 | GO:0034399 | nuclear periphery(GO:0034399) |
0.1 | 0.8 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.8 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.5 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 4.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.7 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.7 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.1 | 0.5 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 6.8 | GO:0005814 | centriole(GO:0005814) |
0.1 | 0.4 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 2.9 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.1 | 0.4 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.9 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.3 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 0.3 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 2.0 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 0.5 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 13.1 | GO:1990234 | transferase complex(GO:1990234) |
0.1 | 0.1 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 0.6 | GO:0036452 | ESCRT complex(GO:0036452) |
0.1 | 1.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.1 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.1 | 0.9 | GO:0070461 | SAGA-type complex(GO:0070461) |
0.1 | 2.0 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.2 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.7 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.9 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 36.0 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 2.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 1.8 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 7.2 | GO:0097223 | sperm part(GO:0097223) |
0.1 | 0.5 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.2 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.1 | 0.7 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.1 | 0.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.9 | GO:0031011 | Ino80 complex(GO:0031011) |
0.1 | 5.1 | GO:0030016 | myofibril(GO:0030016) |
0.1 | 27.3 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.7 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 2.1 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 13.8 | GO:0005912 | adherens junction(GO:0005912) |
0.1 | 1.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.6 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 3.8 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 0.2 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 0.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 5.1 | GO:0044391 | ribosomal subunit(GO:0044391) |
0.1 | 1.8 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 99.1 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 237.1 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 0.9 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.5 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.1 | 0.2 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.1 | 5.1 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.1 | 0.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.4 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.1 | 1.3 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 2.3 | GO:0034703 | cation channel complex(GO:0034703) |
0.0 | 0.0 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 4.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.3 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.0 | 0.2 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.0 | 0.0 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 8.0 | GO:0005856 | cytoskeleton(GO:0005856) |
0.0 | 0.1 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.8 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.0 | GO:0032433 | filopodium tip(GO:0032433) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.2 | 27.5 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
9.0 | 26.9 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
5.0 | 10.0 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
4.0 | 11.9 | GO:0004771 | sterol esterase activity(GO:0004771) |
4.0 | 11.9 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
3.9 | 15.7 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
3.8 | 11.5 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
3.8 | 7.6 | GO:0070644 | vitamin D response element binding(GO:0070644) |
3.7 | 33.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
3.3 | 10.0 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
3.2 | 9.6 | GO:0038181 | bile acid receptor activity(GO:0038181) |
3.2 | 9.5 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
3.1 | 15.3 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
2.8 | 11.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
2.6 | 7.9 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
2.5 | 9.9 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
2.5 | 7.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
2.3 | 4.6 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
2.2 | 11.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
2.2 | 13.0 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
2.0 | 7.9 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
1.8 | 5.3 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.7 | 5.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.7 | 1.7 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
1.6 | 11.3 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
1.6 | 4.8 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.6 | 7.9 | GO:0016151 | nickel cation binding(GO:0016151) |
1.5 | 19.8 | GO:0015643 | toxic substance binding(GO:0015643) |
1.5 | 5.9 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
1.5 | 4.4 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
1.5 | 4.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.5 | 5.8 | GO:0070888 | E-box binding(GO:0070888) |
1.3 | 4.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
1.3 | 8.0 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
1.3 | 9.4 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
1.3 | 4.0 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
1.3 | 3.9 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.3 | 3.9 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.3 | 11.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
1.3 | 5.1 | GO:0032564 | dATP binding(GO:0032564) |
1.3 | 13.9 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
1.3 | 1.3 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
1.3 | 3.8 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.3 | 3.8 | GO:0055100 | adiponectin binding(GO:0055100) |
1.2 | 10.0 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
1.2 | 8.5 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
1.2 | 4.8 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
1.2 | 5.9 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
1.2 | 2.3 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
1.2 | 17.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
1.2 | 4.6 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.1 | 2.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
1.1 | 15.9 | GO:0070402 | NADPH binding(GO:0070402) |
1.1 | 3.4 | GO:0032190 | acrosin binding(GO:0032190) |
1.1 | 5.7 | GO:0017040 | ceramidase activity(GO:0017040) |
1.1 | 38.4 | GO:0051723 | protein methylesterase activity(GO:0051723) |
1.1 | 27.0 | GO:0030552 | cAMP binding(GO:0030552) |
1.1 | 12.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
1.1 | 3.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
1.1 | 3.3 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
1.1 | 3.3 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
1.1 | 3.3 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
1.1 | 3.2 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
1.1 | 5.3 | GO:0070728 | leucine binding(GO:0070728) |
1.1 | 1.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
1.0 | 3.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.0 | 1.0 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
1.0 | 2.1 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
1.0 | 3.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
1.0 | 6.1 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
1.0 | 3.0 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
1.0 | 5.0 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
1.0 | 3.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.0 | 4.0 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
1.0 | 2.0 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
1.0 | 2.0 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
1.0 | 2.9 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
1.0 | 2.9 | GO:0019862 | IgA binding(GO:0019862) |
0.9 | 3.8 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.9 | 5.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.9 | 2.8 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.9 | 3.6 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.9 | 4.5 | GO:0008430 | selenium binding(GO:0008430) |
0.9 | 2.7 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.9 | 17.9 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.9 | 9.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.9 | 0.9 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.9 | 19.9 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.9 | 5.2 | GO:0002054 | nucleobase binding(GO:0002054) |
0.9 | 2.6 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.9 | 2.6 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.9 | 3.4 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.8 | 7.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.8 | 3.4 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.8 | 0.8 | GO:0030911 | TPR domain binding(GO:0030911) |
0.8 | 0.8 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.8 | 2.5 | GO:0005119 | smoothened binding(GO:0005119) |
0.8 | 9.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.8 | 16.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.8 | 3.2 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.8 | 2.4 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.8 | 8.7 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.8 | 8.7 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.8 | 2.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.8 | 5.5 | GO:0046790 | virion binding(GO:0046790) |
0.8 | 2.4 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.8 | 2.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.8 | 5.5 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.8 | 3.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.8 | 13.9 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.8 | 0.8 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.8 | 1.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.8 | 5.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.8 | 3.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.8 | 10.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.8 | 7.6 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.8 | 4.5 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.7 | 4.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.7 | 8.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.7 | 3.7 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.7 | 1.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.7 | 1.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.7 | 3.5 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.7 | 2.8 | GO:0097001 | ceramide binding(GO:0097001) |
0.7 | 2.8 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.7 | 2.7 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.7 | 2.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.7 | 0.7 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.7 | 2.6 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.7 | 3.9 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.7 | 3.3 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.6 | 11.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.6 | 7.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.6 | 1.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.6 | 1.3 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.6 | 10.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.6 | 1.3 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.6 | 1.9 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.6 | 3.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.6 | 2.5 | GO:0043515 | kinetochore binding(GO:0043515) |
0.6 | 12.9 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.6 | 9.6 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.6 | 9.6 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.6 | 8.9 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.6 | 1.8 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.6 | 12.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.6 | 3.0 | GO:0005499 | vitamin D binding(GO:0005499) |
0.6 | 1.8 | GO:0004096 | catalase activity(GO:0004096) |
0.6 | 1.2 | GO:0070538 | oleic acid binding(GO:0070538) |
0.6 | 5.3 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.6 | 1.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.6 | 1.8 | GO:0050692 | DBD domain binding(GO:0050692) |
0.6 | 0.6 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.6 | 1.2 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.6 | 1.7 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.6 | 1.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.6 | 7.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.6 | 23.3 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.6 | 6.8 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.6 | 12.5 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.6 | 1.1 | GO:0008494 | translation activator activity(GO:0008494) |
0.6 | 2.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.6 | 1.7 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.6 | 2.3 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
0.6 | 0.6 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.6 | 2.8 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.6 | 1.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.6 | 2.2 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.5 | 3.3 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.5 | 2.2 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.5 | 2.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.5 | 15.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.5 | 1.6 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.5 | 2.2 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.5 | 5.4 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.5 | 4.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.5 | 2.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.5 | 2.7 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.5 | 3.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.5 | 2.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.5 | 3.2 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.5 | 11.1 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.5 | 2.6 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.5 | 1.1 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.5 | 3.2 | GO:0004064 | arylesterase activity(GO:0004064) |
0.5 | 10.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.5 | 3.1 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.5 | 2.6 | GO:0005113 | patched binding(GO:0005113) |
0.5 | 2.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.5 | 3.1 | GO:0043426 | MRF binding(GO:0043426) |
0.5 | 6.7 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.5 | 1.6 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.5 | 2.1 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.5 | 3.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.5 | 1.5 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.5 | 12.8 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.5 | 2.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.5 | 1.5 | GO:2001070 | starch binding(GO:2001070) |
0.5 | 2.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.5 | 1.5 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.5 | 5.0 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.5 | 2.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.5 | 1.5 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.5 | 2.0 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.5 | 1.0 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.5 | 5.9 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.5 | 1.0 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.5 | 1.0 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.5 | 2.0 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.5 | 4.4 | GO:0016208 | AMP binding(GO:0016208) |
0.5 | 1.5 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.5 | 5.3 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.5 | 1.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.5 | 1.0 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.5 | 2.4 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.5 | 0.5 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.5 | 1.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.5 | 1.0 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.5 | 1.9 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.5 | 2.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.5 | 0.9 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.5 | 6.5 | GO:0050661 | NADP binding(GO:0050661) |
0.5 | 2.8 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.5 | 0.9 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.5 | 1.8 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.5 | 2.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.5 | 0.9 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.5 | 1.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.5 | 4.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.5 | 1.4 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.5 | 3.6 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.5 | 3.6 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.5 | 1.4 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.4 | 8.1 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.4 | 15.2 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.4 | 2.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.4 | 1.8 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.4 | 1.3 | GO:0035671 | enone reductase activity(GO:0035671) |
0.4 | 2.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.4 | 1.3 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.4 | 2.2 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.4 | 3.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.4 | 0.4 | GO:0015927 | trehalase activity(GO:0015927) |
0.4 | 0.4 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.4 | 2.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.4 | 0.4 | GO:0016751 | succinyltransferase activity(GO:0016748) S-succinyltransferase activity(GO:0016751) |
0.4 | 1.3 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.4 | 0.4 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.4 | 3.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.4 | 6.3 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.4 | 3.7 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.4 | 0.8 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.4 | 2.5 | GO:0003680 | AT DNA binding(GO:0003680) |
0.4 | 0.4 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.4 | 0.8 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.4 | 6.9 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.4 | 5.7 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.4 | 0.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.4 | 11.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.4 | 11.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.4 | 2.0 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.4 | 0.8 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.4 | 1.2 | GO:0004359 | glutaminase activity(GO:0004359) |
0.4 | 1.2 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.4 | 1.2 | GO:0004802 | transketolase activity(GO:0004802) |
0.4 | 1.6 | GO:1990254 | keratin filament binding(GO:1990254) |
0.4 | 1.6 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.4 | 0.4 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.4 | 0.8 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.4 | 3.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 1.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.4 | 0.8 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.4 | 0.4 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.4 | 1.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.4 | 0.8 | GO:0004103 | choline kinase activity(GO:0004103) |
0.4 | 5.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.4 | 3.1 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.4 | 0.8 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.4 | 0.4 | GO:0035870 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.4 | 1.5 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.4 | 0.8 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.4 | 2.2 | GO:0043495 | protein anchor(GO:0043495) |
0.4 | 1.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.4 | 0.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.4 | 2.6 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.4 | 0.7 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.4 | 1.5 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.4 | 8.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.4 | 2.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.4 | 1.5 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.4 | 1.5 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.4 | 0.4 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.4 | 1.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.4 | 2.9 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.4 | 4.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.4 | 1.8 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.4 | 6.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.4 | 0.4 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.4 | 1.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.4 | 0.4 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.4 | 1.1 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.4 | 6.8 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.4 | 2.1 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.4 | 4.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.4 | 1.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.3 | 1.4 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.3 | 1.0 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.3 | 1.0 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 2.4 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.3 | 5.9 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.3 | 1.4 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.3 | 1.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.3 | 1.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 1.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.3 | 9.9 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.3 | 1.7 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 1.4 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.3 | 1.0 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.3 | 2.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.3 | 4.6 | GO:0030955 | potassium ion binding(GO:0030955) |
0.3 | 0.7 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.3 | 4.6 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.3 | 1.0 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.3 | 2.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.3 | 2.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.3 | 1.6 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.3 | 3.2 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 24.6 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.3 | 0.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 1.0 | GO:0035877 | death effector domain binding(GO:0035877) |
0.3 | 0.3 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.3 | 1.9 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.3 | 11.8 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.3 | 0.6 | GO:0035939 | microsatellite binding(GO:0035939) |
0.3 | 1.6 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.3 | 13.2 | GO:0000049 | tRNA binding(GO:0000049) |
0.3 | 4.7 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.3 | 0.6 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.3 | 4.7 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.3 | 3.1 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.3 | 0.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.3 | 1.5 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.3 | 4.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.3 | 2.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.3 | 1.2 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.3 | 4.0 | GO:0043274 | phospholipase binding(GO:0043274) |
0.3 | 5.2 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.3 | 0.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.3 | 1.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.3 | 0.6 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.3 | 0.6 | GO:0000339 | RNA cap binding(GO:0000339) |
0.3 | 1.8 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.3 | 3.0 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.3 | 1.2 | GO:0004549 | ribonuclease P activity(GO:0004526) tRNA-specific ribonuclease activity(GO:0004549) |
0.3 | 1.5 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.3 | 0.3 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.3 | 4.1 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 2.6 | GO:0070990 | snRNP binding(GO:0070990) |
0.3 | 3.8 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.3 | 2.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.3 | 0.9 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.3 | 0.6 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.3 | 0.9 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.3 | 1.7 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.3 | 27.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.3 | 0.6 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.3 | 0.9 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.3 | 0.3 | GO:0030352 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity(GO:0030351) inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity(GO:0030352) inositol pentakisphosphate phosphatase activity(GO:0052827) |
0.3 | 1.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.3 | 1.4 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.3 | 1.7 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.3 | 1.4 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.3 | 8.5 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.3 | 3.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.3 | 1.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.3 | 0.6 | GO:0048185 | activin binding(GO:0048185) |
0.3 | 0.3 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.3 | 1.4 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.3 | 1.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 0.8 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.3 | 4.4 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.3 | 15.5 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.3 | 0.6 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.3 | 0.8 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.3 | 0.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.3 | 0.5 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.3 | 20.3 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.3 | 1.6 | GO:0018499 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.3 | 1.1 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.3 | 1.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.3 | 1.6 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.3 | 0.8 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.3 | 5.2 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.3 | 9.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.3 | 0.8 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.3 | 2.3 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.3 | 0.8 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.3 | 1.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.3 | 2.0 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.3 | 0.3 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.2 | 2.2 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 2.7 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.2 | 1.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.2 | 4.4 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.2 | 0.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.2 | 1.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 0.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.2 | 1.9 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.2 | 2.4 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.2 | 1.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 1.2 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 0.9 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 0.9 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.2 | 0.7 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.2 | 1.2 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.2 | 0.7 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 0.7 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.2 | 1.6 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.2 | 2.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 0.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.2 | 0.5 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.2 | 0.7 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 1.6 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 1.6 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 0.2 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.2 | 0.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 0.9 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.2 | 1.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 29.9 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.2 | 13.4 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.2 | 0.9 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 10.0 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 0.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 0.4 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 1.3 | GO:0003896 | DNA primase activity(GO:0003896) |
0.2 | 2.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.2 | 0.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 0.6 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.2 | 1.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 8.9 | GO:0035064 | methylated histone binding(GO:0035064) |
0.2 | 1.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 0.9 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 2.7 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 0.8 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.2 | 0.6 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 1.9 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.2 | 0.2 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.2 | 0.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.2 | 0.6 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 0.8 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.2 | 0.2 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.2 | 1.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 2.7 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 1.9 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.2 | 2.5 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.2 | 2.5 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 0.4 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 0.6 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 4.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 1.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 2.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 0.6 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 3.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 2.8 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 3.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 0.4 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.2 | 0.4 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.2 | 0.6 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.2 | 0.8 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.2 | 1.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 0.4 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.2 | 5.6 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.2 | 2.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.6 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.2 | 0.6 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.2 | 4.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 1.9 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.2 | 2.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 3.9 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.2 | 3.9 | GO:0034792 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.2 | 6.1 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.2 | 1.8 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.2 | 1.5 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.2 | 0.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 2.2 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.2 | 5.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 0.7 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.2 | 0.4 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.2 | 0.4 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.2 | 5.5 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.2 | 0.2 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.2 | 149.6 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.2 | 0.9 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 0.3 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 3.7 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 0.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.2 | 0.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 1.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.2 | 0.5 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.2 | 0.7 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 0.8 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 0.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 0.2 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.2 | 0.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.2 | 0.3 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.2 | 0.3 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.2 | 4.6 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.2 | 1.8 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 2.1 | GO:0030276 | clathrin binding(GO:0030276) |
0.2 | 0.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 0.6 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.2 | 0.2 | GO:0046977 | TAP binding(GO:0046977) |
0.2 | 0.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 0.6 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.2 | 2.6 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.2 | 9.0 | GO:0004386 | helicase activity(GO:0004386) |
0.2 | 1.4 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 18.0 | GO:0008017 | microtubule binding(GO:0008017) |
0.2 | 0.3 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.9 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.7 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 1.8 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.6 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 1.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 1.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.1 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.1 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 1.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 4.6 | GO:0035326 | enhancer binding(GO:0035326) |
0.1 | 2.9 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 2.1 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.4 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 1.4 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 1.7 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 0.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 3.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.3 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 4.9 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 2.9 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.1 | 1.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.5 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 1.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.3 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.1 | 0.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 1.5 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 2.9 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 2.0 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.9 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.5 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.5 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.1 | 0.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.3 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.1 | 0.6 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.6 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.1 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 1.0 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.6 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.1 | 2.3 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 2.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.1 | GO:0048030 | disaccharide binding(GO:0048030) |
0.1 | 0.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 0.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 1.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.9 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 0.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 10.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.4 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 2.8 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 1.7 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.1 | 0.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.7 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 1.3 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.4 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.1 | 2.2 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.7 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 2.6 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.1 | 0.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 2.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 1.0 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.1 | 65.9 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.7 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.9 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 2.5 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 0.4 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 1.6 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 2.0 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 0.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 1.9 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.8 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 11.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 2.1 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.6 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.8 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.1 | 2.0 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.4 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.1 | 0.7 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 1.8 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.1 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.2 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.1 | 0.3 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.1 | 3.7 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 0.2 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.1 | 0.1 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.1 | 3.3 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 9.8 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.1 | 0.5 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 0.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 9.2 | GO:0032561 | guanyl ribonucleotide binding(GO:0032561) |
0.1 | 0.1 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.1 | 0.3 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 0.7 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 2.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.8 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 0.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 2.5 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 4.7 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 0.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.9 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.1 | 0.3 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.5 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.2 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 2.7 | GO:0005254 | chloride channel activity(GO:0005254) |
0.1 | 0.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.1 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.1 | 0.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 1.5 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.8 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 0.2 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.2 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 2.6 | GO:0000988 | transcription factor activity, protein binding(GO:0000988) |
0.1 | 0.2 | GO:0070815 | procollagen-lysine 5-dioxygenase activity(GO:0008475) peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 25.4 | GO:0008270 | zinc ion binding(GO:0008270) |
0.1 | 0.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.5 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 2.1 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.1 | 0.1 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 0.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 2.8 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.1 | 0.4 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 4.9 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 0.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.8 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 0.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.2 | GO:0001164 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.1 | 1.2 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.0 | 0.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.0 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.0 | 0.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 2.1 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.0 | 0.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.0 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.5 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.0 | 0.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.4 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.7 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.1 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.0 | 0.1 | GO:0051870 | methotrexate binding(GO:0051870) |
0.0 | 0.0 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.2 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.0 | 0.2 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.4 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.0 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.3 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.2 | GO:0015108 | chloride transmembrane transporter activity(GO:0015108) |
0.0 | 16.3 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 2.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 0.1 | GO:0034956 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.0 | 2.6 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 1.1 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.7 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.2 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.2 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.0 | 0.1 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.2 | GO:0019825 | oxygen binding(GO:0019825) |
0.0 | 0.4 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.1 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 3.1 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.0 | 0.6 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 4.3 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.0 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.0 | 0.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.1 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 8.6 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.1 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.0 | 0.0 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.0 | 0.0 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 0.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.2 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.0 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 41.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.4 | 36.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
1.2 | 36.8 | ST ADRENERGIC | Adrenergic Pathway |
1.1 | 11.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.9 | 28.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.8 | 1.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.8 | 3.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.7 | 29.0 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.6 | 6.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.6 | 5.7 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.6 | 15.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.5 | 22.0 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.5 | 3.5 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.5 | 3.5 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.5 | 11.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.5 | 11.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.5 | 5.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.5 | 4.6 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.4 | 4.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.4 | 12.0 | PID SHP2 PATHWAY | SHP2 signaling |
0.4 | 10.8 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.4 | 3.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.4 | 1.6 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.4 | 23.6 | PID P73PATHWAY | p73 transcription factor network |
0.4 | 10.0 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.4 | 1.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 4.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.3 | 13.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 7.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.3 | 5.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.3 | 11.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.3 | 3.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.3 | 1.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 4.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.3 | 1.1 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.3 | 5.7 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 7.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.3 | 1.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 1.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.3 | 4.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.3 | 8.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.3 | 2.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 3.9 | PID ATM PATHWAY | ATM pathway |
0.3 | 4.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.3 | 4.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 1.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 2.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 2.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 0.2 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 0.7 | ST STAT3 PATHWAY | STAT3 Pathway |
0.2 | 2.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 3.9 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 2.0 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 0.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.2 | 2.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 6.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 0.4 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 3.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 3.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 2.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 0.6 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.2 | 1.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 6.5 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 0.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 2.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 1.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 2.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 0.9 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 2.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 0.9 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 2.1 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 0.2 | PID MYC PATHWAY | C-MYC pathway |
0.2 | 0.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 1.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 2.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 3.0 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 4.1 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 1.8 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 0.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 0.9 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 1.9 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 1.6 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 2.7 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 2.4 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 1.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 1.6 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 0.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 0.6 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 1.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 4.1 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 1.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 1.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 1.0 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 1.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 11.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 1.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 1.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 1.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.1 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 0.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 40.8 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
1.8 | 10.6 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
1.7 | 3.4 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
1.6 | 15.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.5 | 22.3 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
1.4 | 21.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
1.3 | 15.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
1.3 | 16.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
1.2 | 12.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
1.2 | 12.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
1.2 | 2.4 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
1.2 | 16.9 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
1.1 | 9.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.0 | 6.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
1.0 | 11.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.9 | 7.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.9 | 2.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.9 | 26.8 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.9 | 16.2 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.9 | 7.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.9 | 3.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.9 | 0.9 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.9 | 2.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.8 | 3.4 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.8 | 17.4 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.8 | 17.3 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.8 | 5.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.8 | 6.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.8 | 8.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.8 | 18.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.8 | 10.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.7 | 3.6 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.7 | 3.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.7 | 17.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.7 | 1.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.6 | 28.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.6 | 3.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.6 | 5.5 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.6 | 3.5 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.6 | 6.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.5 | 12.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.5 | 11.3 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.5 | 14.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.5 | 7.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.5 | 5.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.5 | 2.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.5 | 11.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.5 | 4.0 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.5 | 4.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.5 | 6.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.5 | 7.6 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.5 | 0.5 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.5 | 7.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.5 | 76.0 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.5 | 4.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.4 | 5.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.4 | 4.4 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.4 | 1.8 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.4 | 4.4 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.4 | 8.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.4 | 3.4 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.4 | 1.6 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.4 | 4.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.4 | 4.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.4 | 13.2 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.4 | 4.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.4 | 3.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 4.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.4 | 24.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.4 | 7.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.4 | 13.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.4 | 1.5 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.4 | 4.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.4 | 5.4 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.4 | 2.8 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.4 | 3.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.3 | 4.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.3 | 6.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.3 | 7.9 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.3 | 0.3 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.3 | 5.1 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.3 | 4.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.3 | 3.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.3 | 0.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.3 | 0.9 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.3 | 5.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.3 | 2.4 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.3 | 4.1 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.3 | 1.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.3 | 7.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.3 | 1.7 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.3 | 0.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.3 | 3.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.3 | 1.4 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.3 | 9.0 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.3 | 4.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.3 | 11.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.3 | 1.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.3 | 1.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.3 | 0.5 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.3 | 14.0 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.2 | 3.2 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
0.2 | 0.5 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.2 | 4.5 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.2 | 6.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 7.4 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.2 | 3.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 3.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 1.4 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.2 | 5.6 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 9.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.2 | 2.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 2.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 5.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 2.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.2 | 2.6 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 2.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 4.1 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 1.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 7.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 1.7 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 4.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.2 | 0.6 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.2 | 0.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 2.6 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.2 | 4.2 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.2 | 5.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 3.9 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 1.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.2 | 1.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 4.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 0.8 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.2 | 3.9 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 4.6 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 3.4 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 7.8 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.2 | 0.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.2 | 1.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 0.7 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 2.0 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.2 | 3.7 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.2 | 3.7 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.2 | 2.9 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.2 | 1.0 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 19.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 8.1 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 1.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 0.2 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.2 | 1.4 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.2 | 0.6 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.2 | 3.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 2.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 1.9 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 2.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.9 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.6 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 1.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 0.4 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 2.1 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 0.7 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.1 | 1.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 0.9 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 1.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 2.7 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 3.3 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.1 | 7.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.5 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.1 | 2.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 1.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 2.0 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 5.2 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 3.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 4.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 0.8 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 0.5 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.5 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 1.3 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 1.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 2.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 2.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 2.7 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 0.4 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.1 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.1 | 0.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 0.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 1.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.9 | REACTOME M G1 TRANSITION | Genes involved in M/G1 Transition |
0.1 | 0.8 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 1.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 0.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 6.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.7 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.2 | REACTOME G1 S TRANSITION | Genes involved in G1/S Transition |
0.1 | 1.1 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 1.1 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 1.1 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 3.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 1.6 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.0 | 0.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.0 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 0.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.2 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.0 | 0.0 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 4.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 1.3 | REACTOME METABOLISM OF PROTEINS | Genes involved in Metabolism of proteins |
0.0 | 0.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.0 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.1 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.0 | 0.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.1 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |